Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2026 Nov 2;24(11):e3004099. doi: 10.1371/journal.pbio.3004099

LEM-3/ANKLE1 nuclease prevents the formation of abnormal syncytium to safeguard neuronal differentiation

Siyu Deng 1, Chaogu Zheng 1,*
Editor: François Schweisguth2
PMCID: PMC13743039  PMID: 42970577

Abstract

In animal development, cells exit the cell cycle after a final round of cell division to differentiate into specialized cell types. However, the impact of failed cytokinesis on the fate specification of postmitotic cells, especially neurons, remains poorly understood. We analyzed the Caenorhabditis elegans mutants lacking the midbody-tethered endonuclease LEM-3/ANKLE1, which resolves chromatin bridges during cytokinesis. Using genetic analysis, fluorescence microscopy, and RNA visualization, we found that unresolved DNA bridges lead to the formation of stable intercellular bridges, creating binucleate syncytia between touch receptor neurons and sister cells, which allows thorough cytoplasmic mixing despite independent nuclear transcription. In some cases, the cytoplasmic linkage between sister cells also led to the suppression of neuronal fates and prevention of apoptotic fates. Thus, LEM-3 prevents syncytium formation to ensure proper cellular differentiation.


Animal cells typically adopt their terminal identities during the final round of cell division, and so failed cytokinesis can strongly influence fate specification, especially in neurons. This study shows that the midbody-tethered endonuclease LEM-3 prevents syncytium formation to ensure proper cellular differentiation in C. elegans.

Introduction

In development, cells exit the cell cycle after the final round of cell division in order to differentiate into specific cell types. Although in some scenarios, the sister cells that are separated by cytokinesis can adopt the same cell fate, in many cases they adopt different cell fates (either two distinct terminal cell fates or one differentiated fate and one progenitor fate). In those later scenarios, surprisingly little is known about the consequence of failed cytokinesis in terminal differentiation. Can cells, especially neurons, still differentiate if they are physically connected to their sister cells? How does the mixing of cytoplasmic content affect the fate specification of the two sister cells that are supposed to differentiate into distinct cell fates? In this study, we address these questions by studying the Caenorhabditis elegans lem-3(−) mutants, which cause the formation of a persistent cytoplasmic linkage (or a stable intercellular bridge) between sister cells due to failure in resolving chromatin bridges.

LEM-3 is an evolutionarily conserved LEM domain protein that also contains N-terminal Ankyrin repeats and a C-terminal endonuclease domain. lem-3 was initially discovered in a genetic screen for DNA repair genes, as the lem-3(−) mutants were hypersensitive to excessive DNA damage [1]. More recently, LEM-3 was found to localize to the midbody in the late stages of cytokinesis to resolve chromatin bridges (or other DNA bridges) caused by incomplete DNA replication, persistent recombination intermediates, or defects in chromosome condensation or decatenation [2]. The LEM-3 homolog in humans, ANKLE1, shows nuclease activities towards a range of branched DNA species [3,4] and is similarly recruited to the midbody to process chromatin bridges [5], suggesting conserved functions across species. The formation of chromatin bridges delays cytokinesis [6,7], but persistent bridges are eventually cleaved by actomyosin contractile force in continuously dividing cells [8]. However, it remains unclear whether the chromatin bridges would be broken and the intercellular connection be severed following the terminal cell division that generates two postmitotic daughter cells.

In certain tissues, multinucleate syncytium forms normally in development. For example, the C. elegans hypodermis and seam cells are multinucleate syncytia that are generated by cell fusion; in particular, the hyp7 cell is a syncytium containing 139 nuclei [9]. In another example, the germline of C. elegans hermaphrodites arises via incomplete cytokinesis and forms a syncytium in which more than 1,000 nuclei share cytoplasm through stable bridges [10,11]. Muscles also form multinucleated syncytia in various organisms. In the above cases, syncytia connect the same types of cells. The developmental fate of syncytia that connect different types of cells is less clear. Here, we studied this question using the binucleate syncytia formed between sister cells due to unresolved chromatin bridges in lem-3(−) mutants.

Results

The loss of lem-3 results in binucleate syncytia connecting touch receptor neurons (TRNs) and their sister cells through an intercellular bridge

In a forward genetic screen searching for genes that regulate TRN fate specification, we isolated a mutant allele unk14 that caused the expression of TRN markers in extra cells. The wild-type animals have six TRNs, including ALML/R, AVM, PVM, and PLML/R, which were specifically labeled by the mec-17p::TagRFP transgene, whereas unk14 mutants showed extra cells near AVM and PLM cell bodies in ~15% of the animals at 25 °C. Strikingly, the extra cells were physically connected with the AVM and PLM cell body through an stable intercellular bridge, which is also marked by TagRFP (Fig 1A – 1D). Using chromosomal mapping and whole-genome resequencing, we mapped unk14 to a mutation in lem-3, which codes for a midbody-tethered, LEM domain-containing DNA endonuclease [2,12]. The mutation caused a V618M substitution in the LEM-3 protein. To confirm that the loss of lem-3 caused the phenotype of producing extra TRN-like cells, we tested a nonsense allele of lem-3, named mn155(R190*), which caused a similar phenotype and failed to complement unk14. We also generated lem-3 knockout alleles (unk84 and unk85) using CRISPR/Cas9-mediated gene editing and found that these alleles also led to the presence of extra cells labeled by TagRFP. Importantly, the extra TRN phenotype in lem-3(−) mutants was confirmed using other TRN fate markers (S1A and S1B Fig) and can be rescued by a transgene carrying a wild-type copy of lem-3(+), further confirming that the loss of lem-3 resulted in developmental defects in restricting TRN fate in the six canonical TRNs (Fig 1E).

Fig 1. Mutations in lem-3 lead to the formation of syncytia between TRNs and their sister cells.

Fig 1

(A) Schematic cartoon of the lem-3 gene structure and LEM-3 protein domain structure, as well as the molecular lesion of the lem-3 alleles used. (B) The presence of both TRN marker uIs115[mec-17p::TagRFP] and SDQL/R marker uIs130[lad-2p::GFP] in the AVM-SDQR and PVM-SDQL syncytia in lem-3(unk84) mutants. Arrows point to the intercellular bridge connecting the two cell bodies. Scale bars = 20 μm. (C) ALML-BDUL syncytium expresses TRN marker but does not express BDU marker otIs14[zig-3p::GFP] in lem-3(unk84) mutants. “Z1” and “Z2” mean two focal planes of the same animal. (D) PLMR-ALNR syncytium expresses the TRN marker but not the ALN marker uIs130[lad-2p::GFP] (which also labels PLN). (E) The penetrance of binucleate syncytium connected by the bridge for the four TRN subtypes at 25oC for the four lem-3 mutants. The syncytium disappeared when the wild-type lem-3(+) was expressed in lem-3(unk84) mutants. Mean ± SD is shown. Single, double, and triple asterisks indicate p < 0.05, 0.01, and 0.001, respectively, in a post-ANOVA Tukey’s HSD test comparing the mutants with the wild-type or selected pairs. The data underlying this Figure can be found in S1 Data.

Previous studies found that during the early cell divisions of C. elegans embryos, LEM-3 is recruited to the midbody from anaphase to the late stage of cytokinesis to resolve chromatin bridges caused by various errors in DNA replication, recombination, or chromosome condensation [2]. The presence of chromatin bridges (and possibly ultra-fine DNA bridges) delays abscission through the activation of Aurora B kinase-mediated NoCut pathway [6]. Aurora B activates LEM-3, which cleaves the DNA bridge and allows cytokinesis to proceed. In lem-3(−) mutants, chromatin bridges are not processed and are eventually broken by actomyosin dependent-mechanical force, which results in error-prone repair and chromosomal rearrangement [13]. This forced break of chromatin bridges by cytokinesis was found in continuously dividing cells in culture or in the early embryos. However, the persistence of the cytoplasmic bridges connecting TRNs and presumably their sister cells in adult animals (>3 days after the scheduled cell division) led us to hypothesize that cytokinesis was not only delayed but aborted in response to the chromatin bridges in the last round of cell division that generates postmitotic cells.

We confirmed that the extra cells labeled by the TRN markers are the sister cells of TRNs by examining the cellular features for each of the four TRN subtypes in the lem-3(−) mutants. For the postembryonic AVM neuron, the extra cell connected with it resembled the morphology of its sister cell SDQR neuron (S1C Fig), contained a nucleus labeled by histones (S1D Fig), and expressed SDQ markers lad-2p::GFP, flp-12p::GFP, ast-1::GFP, and ser-2p2::GFP (Figs 1B and S1E). Interestingly, AVM was also labeled by the SDQ marker, suggesting the co-expression of cell fate markers in the binucleate syncytium. Similar results were obtained for PVM-SDQL syncytium, although its occurrence has much lower penetrance (<3%) than the AVM-SDQR syncytium (10%–20%) (Figs 1B and S1F).

The sister cell of ALM is the peptidergic interneuron BDU. We observed the ALM-BDU syncytium in ~5% of the lem-3(−) mutants. In some cases, the ALM cell body is directly connected with the BDU cell body (Fig 1C), while in other cases, a bridge linked the ALM cell body or its anterior neurite with the BDU posterior neurite (S1A and S2A–S2C Figs). Despite that ALM and BDU migrate towards the opposite directions after the cell division, their physical connection is maintained throughout development into adulthood and reaches >100 μm in length in adults. BDU markers zig-3p::GFP, nlp-80p::GFP, C15C7.4p::GFP, and flp-10p::GFP were not expressed in the ALM-BDU syncytium (Figs 1C and S2A), suggesting that the BDU fate was suppressed by the linkage with ALM. Nevertheless, we found exceptions in two BDU markers ceh-14::EGFP and ser-2p2::GFP, whose expression persisted in the ALM-BDU syncytium, suggesting that the suppression of BDU fate may be incomplete (S2B Fig). In fact, the morphology of the ALM-connected BDU largely resembled the normal BDU, indicating at least partial differentiation of the BDU fate (S2C Fig).

In the case of PLM, the TRN fate dominated over the fate of its sister cell, ALN neuron, when the two cells were connected. The PLM-ALN syncytium was only labeled by the TRN markers (e.g., mec-17p::TagRFP, mec-4p::YFP, and mec-18p::GFP) and not by the ALN markers (e.g., lad-2p::GFP, nlp-20p::GFP, ast-1::GFP, and ser-2p2::GFP) in lem-3(−) mutants (Figs 1D, S1A, and S2D–S2E). Whenever an extra cell was labeled by the TRN marker, we observed the loss of a GFP-labeled ALN neuron, which indicated that the formation of PLM-ALN connections converted the ALN neuron into PLM-like cells.

The significant variation in the penetrance of the syncytium phenotype among the TRN subtypes is intriguing (Fig 1E). We suspect that the subtypes’ different lineage histories, developmental timing, anatomical positions along the body, and physical distance with their sister cells might contribute to such variation in penetrance.

Ectopic presence of MEC-3 converts TRN sisters into TRN-like fate

The suppression of BDU and ALN fates in the ALM-BDU and PLM-ALN syncytia, respectively, could be explained by the presence of the TRN fate selector MEC-3 [14] in the sister neurons via the diffusion through the intercellular bridge (see Fig 3). To test this idea, we expressed mec-3 in all neurons using the unc-119 promoter and found that the forced expression of mec-3 in BDU and ALN neurons indeed activated the TRN fate marker and suppressed the sister fate markers (S3A, S3B Fig), confirming that ectopic presence of MEC-3 in the sister cells can convert them into a TRN-like state. Interestingly, the converted BDU neuron had an ALM-like morphology (e.g., posteriorly displaced cell body, subdorsal axons, and the loss of ventral dip) and did not express any BDU markers (e.g., zig-3p::GFP and ser-2p2::GFP; S3C Fig), suggesting that the fate conversion caused by MEC-3 overexpression is more extensive than that induced by MEC-3 diffusion from the ALM cell body in the ALM-BDU syncytium. Our results are consistent with previous findings that MEC-3 could outcompete the BDU fate selector PAG-3 for binding to the master regulator UNC-86, which is required for the specification of both ALM and BDU fates [15]. Although the ALN fate selector is unknown, we reason that a similar mechanism might allow ectopic MEC-3 to transform ALN into a TRN-like cell.

Fig 2. Two connected cell bodies in the syncytium have distinct transcriptional programs.

Fig 2

(A) smFISH signals for the endogenous mRNAs of TRN fate markers (mec-17, mec-18, and mec-3) and SDQ markers (lad-2, ast-1, flp-12, and ser-2) in the AVM-SDQR syncytia in lem-3(unk84) mutants. The smFISH signals for the wild-type animals were shown in S5 Fig. ser-2 was used as a SDQR but not SDQL marker, since its RNAs were found in WT PVM (the sister of SDQL). uIs31[mec-17p::GFP] was used to label the TRNs and to identify the syncytia formed between TRNs and their sisters. The percentage of the two different phenotypes among the syncytia was shown; at least 20 syncytia were imaged for each probe. Dashed circles indicate the outline of the cell; arrows point to the intercellular bridge. Scale bars = 10 μm. The same applies to other panels. (B) smFISH signals for the mRNAs of TRN and BDU markers (nlp-80, C15C7.4, and D2089.3) in the two cell bodies of the ALM-BDU syncytia. (C) smFISH signals for TRN and ALN markers (nlp-20, lad-2, and ast-1) in the two cell bodies of the PLM-ALN syncytia. “Z1” and “Z2” mean two focal planes of the same animal.

To further confirm that MEC-3 is responsible for the fate conversion, we created lem-3(−); mec-3(−) double mutants and found that the ALM-BDU and PLM-ALN syncytia no longer expressed the TRN markers; instead, they showed the expression of the sister cell markers (S4A–S4C Fig). Interestingly, as previously reported [15], ALM neurons adopted a BDU-like fate and morphology (i.e., ventral shift of cell body and axon) in mec-3(−) mutants, but PLM did not adopt the ALN fate.

Independent transcriptional programs of the two nuclei in the syncytium

The co-labeling of AVM-SDQR and PVM-SDQL syncytia by both TRN and the sister cell fate markers could result from either 1) active transcription of both fate reporters in the two nuclei of the syncytia due to the mixing of cell fate determinants or 2) the diffusion of fluorescent proteins produced only in one cell body. To discern the two possibilities, we visualize the transcription of the cell fate-associated genes from their endogenous loci in the binucleate syncytia using single-molecule fluorescence in situ hybridization (smFISH). In the majority of the AVM-SDQR syncytium, only the AVM cell body contained the mRNAs of TRN genes (e.g., mec-17, mec-18, and mec-3), while only the SDQR cell body contained the mRNAs of SDQ genes (lad-2, ast-1, flp-12, and ser-2; Figs 2A and S5), suggesting that the two cells transcribed different genetic programs despite the cytoplasmic connection. This transcriptional independence was not due to the lack of selector diffusion (see below) but to the inability of the selectors to activate their downstream genes in the nucleus of the sister cell. We reason that a restrictive chromatin state, as previously suggested [16,17], may have prevented the activation of alternative fate programs by the ectopic terminal selectors and avoided the mixing of cell fate at the transcriptional level in most AVM-SDQR syncytia.

However, in about 15% of the animals, we did observe both nuclei of the syncytium actively transcribing the TRN genes, suggesting that the TRN and SDQ fates could be co-expressed from the same nucleus in some cases (Fig 2A). This result is consistent with the finding that forced overexpression of mec-3 in SDQR can turn on the TRN fate without repressing the SDQR fate (S3A and S3C Fig), suggesting that a high level of ectopic MEC-3 can enable the co-existence of TRN and SDQ fate in the same cell. Moreover, the activation of the TRN genes in SDQR of the syncytium required MEC-3, since the syncytium no longer expressed the TRN marker and only expressed the SDQ marker in lem-3(−); mec-3(−) mutants (S4D, S4E Fig). Interestingly, two SDQ fate markers flp-12 and ser-2 were activated in ~40% of the AVM nuclei, suggesting that some AVM may adopt a partially mixed fate in the syncytium. The PVM-SDQL syncytium was similar to the AVM-SDQR pair but with a higher frequency of cell fate mixing (S6A Fig).

For the ALM-BDU syncytium, we found that both nuclei transcribed endogenous TRN fate markers in all cases, and the expression of BDU fate markers (e.g., nlp-80, C15C7.4, D2089.3, ser-2) was suppressed to various degrees (Figs 2B, S5, and S6), which supports the conversion of BDU into a TRN-like fate due to the diffusion of MEC-3. A similar fate conversion of ALN neurons was observed in the PLM-ALN syncytium, since both cell bodies showed the mRNAs for TRN genes and did not contain the mRNAs for the ALN genes (e.g., nlp-20, lad-2, and ser-2) (Fig 2C), which confirmed the suppression of ALN fate in the syncytium due to the diffusion of MEC-3 from PLM to the ALN. Interestingly, the ALN gene ast-1 persisted in the ALN nucleus of all the PLM-ALN syncytia, suggesting that the fate conversion is still partial (Fig 2C). It is worth noting that although the otIs358[ser-2p2::GFP] reporter is not expressed in wild-type ALM and PLM neurons, we detected ser-2 mRNAs in ~60% of the TRNs, making it a suboptimal marker for the sister fate (S5C and S5D Fig). Nevertheless, we still observed the suppression of ser-2 mRNA expression in 13% and 38% of ALM-BDU and PLM-ALN syncytia, respectively, compared to their 100% presence in the wild-type BDU and ALN neurons (S6B and S6C Fig). The above results suggest that the transcriptomes of the two nuclei in a syncytium are not necessarily synchronized and can be independently regulated. The fate specification programs of the TRNs and their sister cells appear to have different susceptibilities to perturbation caused by the cytoplasmic linkage between them.

The mixing of cellular contents between two physically connected cells

The AVM-SDQR syncytium provided an opportunity to understand the extent of cytoplasmic mixing between two transcriptionally (and presumably also translationally) independent but physically connected cells. When labeled by the mec-17p::GFP reporter, GFP mRNA was only detected in the AVM cell body of the syncytia (Figs 3A and S6D), but the GFP protein diffused to fill the entire syncytium, including neuronal processes, suggesting that cytoplasmic soluble proteins can pass through the intercellular bridge. To confirm this idea, we expressed the photoconvertible Dendra2 from the mec-17 promoter in the AVM-SDQR syncytium, photoconverted Dendra2 from green to red only in the AVM cell body, and observed the red fluorescent signal in the SDQR cell bodies within minutes (Fig 3B and 3C). Similar results were obtained in the ALM-BDU syncytium, although there is a slower kinetics in the increase of Dendra2 signals possibly due to the longer passage way connecting the ALM and BDU cell bodies (S7A and S7B Fig). Moreover, when we severed the intercellular bridge using a UV laser and then photoconverted Dendra2 in AVM or ALM, we could no longer observe the increase of red fluorescence in the sister cells (S7C–S7F Fig), confirming that the bridges mediated the cytoplasmic exchange between TRNs and the sister cells.

Fig 3. Cytoplasmic contents are mixed between the two cell bodies of the syncytium.

Fig 3

(A) smFISH signals for the GFP mRNAs were only observed in the AVM cell body of the AVM-SDQR syncytium in the lem-3(unk84) animals carrying the uIs31[mec-17p::GFP] transgene. (B) A schematic cartoon and fluorescent images of the photoconversion experiments, in which dendra2 in the AVM was photoactivated by a 488-nm laser and the red fluorescence in SDQR was monitored over time. Scale bars = 5 μm. (C) Quantification of the converted dendra2 fluorescence in AVM and SDQR in the time course of photoconversion; a representative case is shown. (D) The change of RFP fluorescence in the SDQR cell body of the AVM-SDQR syncytium after the intercellular bridge was severed. (E) The ratio of RFP fluorescent intensity of SDQR to that of AVM before and after the severing of the bridge. (F) The distribution of various proteins fused with GFP or TagRFP (expressed from the mec-17 promoter) in the AVM-SDQR syncytium. A diffusive TagRFP or GFP was co-expressed to allow the labeling of the syncytium. Arrows point to the signal in the neurites. The data underlying this Figure can be found in S1 Data.

Severing of the bridge also led to the gradual disappearance of the TagRFP (expressed from the TRN-specific mec-17 promoter) in the SDQR over time, supporting that the SDQR nucleus did not activate the mec-17 promoter and the fluorescent protein was produced in AVM and diffused into SDQR (Fig 3D and 3E). This result also indicated that cutting the cytoplasmic linkage between AVM and SDQR may help unmix their cell fates and revert them back to their respective fates.

To assess what types of proteins can pass through the intercellular bridge, we expressed fluorescently tagged cytoplasmic proteins (e.g., MEC-18::GFP), nuclear proteins (e.g., GFP::NLS, MEC-3::EGFP), membrane proteins (e.g., PLCdPH::GFP, MEC-4::TagRFP), ER-associated proteins (e.g., MEC-6::GFP), synaptic vesicle proteins (e.g., GFP::RAB-3), and mitochondrial proteins (e.g., mitochondrial matrix tagged GFP) from TRN promoters, which were activated in the AVM nucleus. The presence of these proteins in the SDQR cell body would indicate that they can pass through the bridge. In all cases, we observed the fluorescent signals at comparable intensity in both cell bodies of the syncytium, indicating that diffusion (and/or transport) of the proteins through the bridge led to even distribution in the two connected cells (Fig 3F). Organelle-associated proteins maintained their normal subcellular localization in both cell bodies, suggesting that they could be potentially functional in both cells. Overall, the mixing of diffusible cytoplasmic content in the binucleate syncytium appeared to be thorough despite the largely distinct gene transcription profiles of the two nuclei.

Unresolved chromatin bridges and connected nuclear envelopes lead to the formation of intercellular bridge

Next, we investigated the cause of the intercellular bridge connecting TRNs and their sister cells in lem-3(−) mutants. Since LEM-3 and its human ortholog ANKLE1 are required to enzymatically process chromatin bridges that arise from mitotic nondisjunction [2,5,12], we hypothesized that the intercellular bridges connecting TRNs and their sister cells were induced by unresolved chromatin bridges in the lem-3(−) mutants. Since the penetrance of the TRN-sister syncytia was low (<3% at 20 °C or lower) in lem-3(−) mutants, we reasoned that the frequency of spontaneous chromosome segregation errors that need to be processed by LEM-3 is low. Interestingly, elevating the C. elegans culturing temperature to 25 °C increased the frequency of AVM-SDQR and PLM-ALN syncytia (Fig 4A), potentially due to the more frequent DNA replication and chromosomal segregation errors at higher temperatures [18–20]. In fact, disrupting DNA synthesis by knocking down the DNA replication licensing factor mcm-7 [2] or treating the animals with the DNA topoisomerase II inhibitor ICRF-193 [21] significantly increased the penetrance of forming the syncytia in lem-3(−) mutants (Fig 4A). Since ICRF-193 is known to induce chromatin bridges and sister chromatid nondisjunction in anaphase [21,22], the result supports that the intercellular bridge was formed due to unresolved chromosomal linkages. Nevertheless, elevated temperatures and the ICRF-193 treatment had only marginal effects on increasing the penetrance of ALM-BDU and PVM-SDQL syncytia (Fig 4B). As controls, treating the wild-type animals with mcm-7 RNAi or ICRF-193 never resulted in the syncytium phenotype.

Fig 4. Unresolved chromatin bridges in lem-3(−) mutants led to the formation of the binucleate syncytium.

Fig 4

(A, B) The penetrance of the TRN syncytia in lem-3(unk84) mutants grown under various conditions. Mean ± SD is shown. Single, double, and triple asterisks indicate p < 0.05, 0.01, and 0.001, respectively, in comparison with the 15 °C condition in a Dunnett’s test. (C) Nuclear envelope (NE) is marked by the ccIs4810[lmn-1p::lmn-1::GFP] transgene and cytoplasm (CP) marked by uIs115[mec-17p::TagRFP] in adult lem-3(unk84) mutants treated with or without 10 μM ICRF-193 in the left panel and by the bqSi226[emr-1p::emr-1::mCherry] transgene during development at 1 hour post telophase of the AVM-SDQR cell division (hpt) and 24 and 48 hours post L1 arrest recovery (hpL1a). Another transgene of a different color was used to label the TRN syncytium. Arrows point to the NE linkage. Scale bars = 5 μm. (D) In the left panel, histone is labeled using the transgene oxTi75[eft-3p::GFP::H2B] and is found in the intercellular bridge (arrow). In the right panel, DAPI staining of fixed lem-3(unk84) mutants shows the presence of DNA in the bridge (arrow). (E) Percentages of syncytia showing NE linkages with two different markers in the presence and absence of 10 μM ICRF-193. Asterisks indicate significance in a t test. (F) The length of the intercellular bridge of the AVM-SDQR syncytia at different times post L1 arrest recovery. (G) Percentages of animals showing AVM-SDQR syncytia with an intercellular bridge at different times post L1 arrest recovery (no statistical significance was found in an ANOVA test). (H) Penetrance for the TRN syncytia in GFP::lem-3 missense mutants gt3311(Y556A G558A) and gt3310(S192A S194A), and lem-3(unk14; V618M). Significance in a Dunnett’s test comparing the mutant with the wild type is shown. (I) PLML-ALNL syncytium in air-2(or207ts) mutants grown at 25 °C from early embryonic stages. “Z1” and “Z2” mean two focal planes of the same animal. The data underlying this Figure can be found in S1 Data.

To confirm the presence of chromatin bridges, we found DNA (visualized by DAPI), histones (H2B), and nuclear envelope markers (e.g., LMN-1/Lamin [23] and EMR-1/Emerin [24]) in the intercellular bridge (Fig 4C and 4D). Importantly, these nuclear envelop linkages (e.g., between AVM and SDQR nuclei) were formed immediately after the telophase of the scheduled cell division and can last for several days throughout development and into the adulthood of the animal. When treating the animals with ICRF-193, we observed much stronger signal for nuclear envelope markers in the intercellular bridge (Fig 4C). Nevertheless, only 20~40% of AVM-SDQR syncytia showed persistent nuclear envelope connection 16 hours after the cell division (i.e., 24 hours after recovery from L1 arrest), suggesting that the DNA bridge could break as the two nuclei migrated away from each other during development (Fig 4E).

In fact, we observed the elongation of the AVM-SDQR bridge from ~6 μm in average length in L1/L2 animals to ~27 μm in adults, and the ALM-BDU bridge can extend to >100 μm in length (Fig 4F). The stretching of the chromatin bridge may have led to the mechanical breakage and the loss of nuclear linkage, but the cytoplasmic linkage through the bridge (a membrane structure) was maintained, likely due to the inactivation of cytokinesis machineries (Fig 4G). Compared to the spontaneously formed chromatin bridges, ICRF-193-induced chromatin bridges appeared to be more resistant to mechanical breakage, likely due to the accumulated chromosomal aberrations, since significantly more syncytia maintained the nuclear membrane connection in adults under ICRF-193 treatment compared to untreated lem-3(−) mutants (Fig 4E). When quantifying the distance between the AVM and SDQR nuclei, we found that some syncytia with long nuclear distance could still maintain the nuclear envelope connection into adulthood in the absence of ICRF-193 treatment, suggesting that some naturally occurring DNA linkages might be strong enough to survive the stretching (S8A and S8B Fig). Interestingly, we also found some rare cases where the two nuclei stayed in the same cell body (thus, there was no bridge); we reason that either furrow ingression never occurred, or regression happened due to the presence of chromatin bridges in lem-3(−) mutants (S8B Fig).

The endonuclease activity of LEM-3 is required to cleave the unresolved chromatin bridges during early embryogenesis [2]. As expected, the Y556A and G558A double mutations in the conserved GIY-YIG nuclease motif caused the formation of TRN-sister cell syncytia at similar penetrance as the lem-3(−) deletion allele (Fig 4H). Interestingly, the V618M mutation found in the unk14 allele we isolated from the genetic screen was also mapped to the nuclease domain. Moreover, Aurora B kinase-mediated phosphorylation of LEM-3 is required for its activity in resolving the bridge and preventing the syncytium, because the S192A and S194A double mutation of the putative Aurora B phosphorylation sites [2] caused phenotypes similar to lem-3(−) mutants. Inactivation of air-2, which codes for Aurora B in C. elegans, also led to the formation of the syncytia connecting TRNs and their sister cells, but we only observed the PLM-ALN syncytia using a temperature-sensitive (and likely partial loss-of-function) air-2 allele (Fig 4I).

In addition to LEM-3, we also examined the effects of other endonucleases, including MUS-81/MUS81, SLX-1/SLX1, and XPF-1/ERCC4, which are involved in resolving Holiday junctions, DNA replication errors, and interstrand crosslinks, as well as DNA repair [25–27]. Nevertheless, we did not observe any TRN-sister syncytium in either xpf-1(−) single mutants or xpf-1(−); mus-81(−) double mutants or mus-81(−) slx-1(−) mutants, suggesting that LEM-3 may have specific functions in cutting chromatin bridges connecting sister cells.

The intercellular bridge contains cytoskeleton structures

When a chromatin bridge forms, LEM-3 is recruited to the midbody, which is a transient microtubule structure formed within the intercellular connection between sister cells prior to abscission [2]. Using the centralspindlin protein ZEN-4/MKLP1 as a midbody marker [28], we first confirmed the recruitment of LEM-3 to the midbody to process the chromatin bridge during the cell division that generates AVM and its sister cell SDQR in wild-type animals treated with ICRF-193 (Fig 5A). In lem-3(−) mutants, the midbody formed normally and persisted in the intercellular bridge for hours, likely because the unresolved chromatin bridges aborted cytokinesis (Fig 5B and 5C). However, the ZEN-4 signal eventually disappeared 6 hours after telophase, suggesting that midbody structure cannot last for a long time if abscission does not occur (Fig 5C).

Fig 5. Failed cytokinesis leads to the formation of intercellular bridge which is stabilized by microtubules.

Fig 5

(A) The colocalization of mCherry::ZEN-4 (expressed from the casIs131 transgene) and LEM-3::GFP (expressed from the unkEx1770 transgene) in the midbody generated from the AVM-SDQR cell division. Wild-type animals were treated with 10 μM ICRF-193 from eggs and imaged at 1-hour post telophase (hpt) of the cell division. Arrow heads point to the midbody. Scale bars = 5 μm. (B) The midbody complex labeled by mCherry::ZEN-4 in the AVM-SDQR syncytium at 1- and 1.5-hours post telophase of the cell division in lem-3(unk84) mutants. Dashed lines indicate the cell bodies, as cytoplasm (CP) is labeled by GFP expressed from ayIs9[egl-17p::GFP]. (C) Tracking of the mCherry::ZEN-4 signal in the same syncytium shows the disappearance of the midbody complex at 6 hpt. (D) Microtubules and F-actin in the intercellular bridge of the AVM-SDQR syncytium is labeled by MAPH-1.1::GFP (MAPH1.1 is a MAP1 family protein) expressed from unkEx170[maph-1.1p::maph-1.1::GFP] and LifeAct::GFP expressed from unkEx572[mec-17p::LifeAct::GFP], respectively. Arrows indicate the bridge. “Z1” and “Z2” mean two focal planes of the same animal. (E) The percentage (mean ± SD) of wild-type (WT) and lem-3(unk84) animals showing the AVM-SDQR syncytia when treated with 1 mM colchicine, 100 nM taxol, 100 nM Y-27632 (ROCK inhibitor), or 1 μM Latrunculin-A (Lat-A). Single asterisk indicates p < 0.05 in comparison with the untreated control in a Dunnett’s test. (F) Left panel shows the percentages of responses of WT animals or lem-3(−) mutants with AVM-SDQR syncytia (AVM*) in a plate dropping assay (~150 responses from >24 animals were recorded). Triple asterisks indicate p < 0.001 in a Fisher’s exact test. The right panel shows the number of reversal responses out of five anterior touches for WT and lem-3(−) animals (~20 animals were tested). The data underlying this Figure can be found in S1 Data.

On the other hand, by visualizing the microtubules using a GFP-fused microtubule-associated protein MAPH-1.1 (a homolog of human MAP1 proteins) [29], we found that microtubule structure persisted in the intercellular bridge and likely provided structural support for the formation and maintenance of the bridge (Fig 5D). Interestingly, treatment with both microtubule-destabilizing and -stabilizing drugs (colchicine and paclitaxel, respectively) reduced the penetrance of AVM-SDQR syncytia, indicating that optimal microtubule stability and dynamics are crucial for forming or maintaining the intercellular bridge (Fig 5E). With the structural support provided by microtubules, the bridge could persist into even aged animals (e.g., day 5 adults; S8C Fig).

Using LifeAct::GFP that binds to actin filaments [30], we also found actin filaments in the intercellular bridge (Fig 5D). The presence of both microtubule and actin cytoskeletons suggested that the bridge may be maintained as a regular neuronal process by the syncytium. However, treating the animals with Latrunculin A that blocks actin polymerization did not affect the penetrance of AVM-SDQR syncytia, suggesting that the formation and maintenance of the bridge may not require actin filaments (Fig 5E). On the contrary, inhibiting ROCK-induced myosin phosphorylation using the ROCK inhibitor Y-27632, which is known to delay furrow ingression [31], significantly increased the penetrance of forming the AVM-SDQR bridge in lem-3(−) mutants (Fig 5E). This finding supports that unresolved chromatin bridges and weaker actomyosin contractility would delay cytokinesis and eventually abort abscission, resulting in permanent intercellular bridges between postmitotic sister cells.

Functional consequences of connecting AVM with its sister cell

In adult animals, AVM functions not only as a mechanosensor but also as a signaling hub to integrate anterior signals through its gap junctions with the two ALM neurons and the connections with downstream interneurons [32,33]. AVM’s role in signal integration and relay is thought to be important for the anterior bias in the response of the touch circuit when all TRNs are activated in a plate tapping assay [34]. Using a similar plate dropping assay that activates both anterior and posterior TRNs, we confirmed that 95% of the wild-type animals responded by reversal, supporting that the anterior TRNs-induced backward movement dominated over the posterior TRNs-induced forward movement. However, only 62% of the lem-3(−) mutants with AVM-SDQR syncytia responded to plate dropping by reversal, and 30% of the animals showed no response, suggesting that anterior and posterior stimulation likely canceled out each other (Fig 5F, left). The anterior bias disappeared in these animals. We confirmed that the lack of response was not due to the loss of mechanosensation in lem-3(−) animals, which showed similar touch sensitivity as the wild-type animals (Fig 5F, right). We reason that when AVM is connected with SDQR, the volume of the cell may grow as twice as the normal AVM, therefore diluting the neural signal (in terms of ion concentrations). Since AVM is activated through gap junctions, the AVM-SDQR syncytium may behave like a bigger sink that raises the threshold of activation and signal propagation. The effects of gap junctions in coupling neurons to increase the activation threshold for sensory stimuli was reported in previous studies [35].

Connection between apoptotic and nonapoptotic cells in lem-3(−) mutants

When examining the AVM-SDQR syncytia, we noticed that ~25% of them had a third cell body, which was connected with the other two cell bodies through intercellular bridges (Fig 6B). We referred to these structures as “three-body syncytia”. Since the sister cell (QR.pp) of the precursor (QR.pa) that generates AVM and SDQR undergoes apoptosis (Fig 6A) [36], we reasoned that this additional cell body may be the remains of the apoptotic cell. This third cell body contained a nucleus labeled by the nuclear envelope marker, was generated through cell division (indicated by the presence of the midbody), but did not transcribe TRN genes (Fig 6B – 6D). Interestingly, as the animal develops, the frequency of the three-body syncytia decreased over time (Fig 6E), implying that the third cell body could be removed (likely through engulfment by other cells) without inducing programmed cell death of the entire syncytium. This finding also suggests that the apoptotic fate of the precursor’s sister (QR.pp) may only be delayed but not reversed through the connection with the surviving AVM and SDQR neurons. In fact, when apoptosis was blocked in lem-3(−); ced-3(−) double mutants, the third cell body persisted over time (Fig 6E).

Fig 6. Binucleate syncytium affects the apoptotic fate of the sister cells.

Fig 6

(A) The cell lineage that generates the precursor of AVM and SDQR and an apoptotic sister (“X” means apoptosis). (B) Three-body syncytia connecting SDQR, AVM, and a third cell body (“3rd”), connected by intercellular bridges (arrows), which contain nuclear envelope (NE) links labeled by LMN-1::GFP. Scale bars = 5 μm. (C) The bridge contains two midbody complexes labeled by mCherry:ZEN-4 (arrow heads) from two rounds of cell divisions that result in the three-body syncytium. (D) smFISH signal for endogenous mec-17 and exogenous GFP in the three-body syncytium of the lem-3(unk84); uIs31[mec-17p::GFP] animals. (E) The percentage of AVM-SDQR syncytia that possess a third body throughout development in lem-3(unk84) and lem-3(unk84); ced-3(n717) animals. (F) The cell lineages that give rise to A/PQR, OLLL/R, and ASER neurons and their apoptotic sisters. (G) Representative images of the two phenotypes were observed for the three types of neurons in lem-3(unk84) mutants: the syncytia formed between them and their apoptotic sisters (“syn” and extra cell body) and the loss of the fate marker labeling (“loss” and dashed circle). (H) Penetrance of the “syn” and “loss” phenotypes for the indicated neuron. Single and double asterisks indicate p < 0.05 and 0.01, respectively, in a Chi-square test comparing the frequencies of the “syn” phenotype between WT and lem-3(−) animals. The number of cells examined is shown above the stacked bar. (I) Representative images of ced-3(n717); ials25 [gcy-37p::GFP] animals showing the extra cells adjacent to AQR and PQR neurons. The bar graph shows the percentages of the cases where the indicated neurons have an extra cell adjacent to them (significance from a t test is shown). The data underlying this Figure can be found in S1 Data.

The above observation prompted us to examine cell divisions that generate one terminally differentiated neuron and one apoptotic cell. Among the four cell types we examined, AQR and PQR neurons form syncytia with their apoptotic sisters at detectable penetrance (2%–3%) through oftentimes a long intercellular bridge (especially for AQR) (Fig 6F and 6G), which may be due to the migratory nature of these neurons [36]. We also observed some rare cases where the AQR and PQR neurons were missing (they likely underwent apoptosis or failed to differentiate), suggesting that neuronal survival and differentiation could also be affected by cytoplasmic connection with cells that were scheduled to die. This may be similar to how cytokinetic bridges in mouse embryos allow the sharing of apoptotic factors to coordinate cell elimination [37]. We did not observe such loss of marker expression in the AVM-SDQR syncytia, likely because only their precursor is connected to an apoptotic sister and thus the effect might be weaker.

Similar results were obtained for OLL, ASER, and PVD neurons with the penetrance of syncytia ranging from 1.6% to 4.7% and the penetrance of cell fate marker loss below 1% (Figs 6F–6H, S9A, and S9B). It appears that connecting a postmitotic neuron with its apoptotic sister is more likely to save the sister cell from dying than to induce apoptosis (or failure in differentiation) of the entire syncytium. No statistically significant phenotype was observed for NSM neurons. To further confirm that blocking apoptosis could rescue the sister cells, we crossed some cell fate markers with ced-3(−) mutants (ced-3 codes for caspase 3) and indeed observed extra cells adjacent to AQR, PQR, and OLL neurons, which were presumably the surviving sister cells (Fig 6I).

LEM-3 safeguards the specification of many neuron types

To understand whether LEM-3 has a general function in preventing the formation of syncytia and safeguarding cell fate specification in the nervous system, we next extended our analysis to 11 other cell divisions that generate two daughter cells with distinct neuronal fates (including the CEPD-URX, SMDD-AIY, SMDV-BAG, ASJ-AUA, ADF-AWB, HSN-PHB, AFD-RMD, ADE-ADA, PDE-PVD precursor, FLP-AIZ, and RIS-DB4 sister pairs). We used fluorescent reporters to mark one of the two cell fates in a sister pair in the lem-3(−) mutants. Interestingly, in almost all cases, we observed both the formation of a syncytium with an additional cell body (presumably the sister cell) and the loss of the marker expression (indicating fate suppression likely due to the connection with the sister cell) with one being the dominant phenotype despite the low penetrance (Figs 7A–7F and S9C–S9G). One exception is the RIS neuron, where we did not observe any significant phenotype in the lem-3(−) mutants, but ICRF-193 treatment led to ~20% of syncytium formation (Figs 7F and S9H). We also used the CEPD-URX sister pair as an example to confirm that the appearance of syncytium labeled by the URX marker (gcy-37p::GFP) coincided with the loss of the CEPD marker (dat-1p::mCherry) in the same animal (Fig 7C). In fact, the penetrance of syncytium for the URX marker was similar to the penetrance of fate loss with the CEPD marker.

Fig 7. Mutations in lem-3 lead to the formation of syncytia for many sister cell pairs.

Fig 7

(A) Dopaminergic neurons CEPDL/R, CEPVL/R, ADEL/R, and PDEL/R are labeled by dat-1p::GFP and show both syncytium (“syn”) and fate loss (“loss” and dashed circle) phenotypes in the lem-3(unk84) mutants. For the syncytia, the abnormally labeled sister cells have their names in yellow; arrows indicate the intercellular bridge. It should be noted that PDE’s sister is the precursor of PVD and its apoptotic sister (see S9A Fig). Scale bars = 5 μm. “Z1”, “Z2”, and "Z3" mean different focal planes of the same animal. (B) URXL/R and AUAL/R are labeled by ynIs78[flp-8p::GFP] and show the syncytium and fate loss phenotypes. (C) The CEPD and URX fates are labeled by dat-1p::mCherry and flp-8p::GFP, respectively, in the same lem-3(−) animal. The fate loss of CEPDR coincides with the URX syncytium. (D, E) Representative images for the syncytium and fate loss phenotypes for BAGL/R and AFDL/R neurons in lem-3(−) mutants. (F) Penetrance of the “syn” and “loss” phenotypes for the indicated neuron. Single and double asterisks indicate p < 0.05 and 0.01, respectively, in a Chi-square test comparing the frequencies of the indicated phenotype between WT and lem-3(−) animals. The number of cells examined is shown above the stacked bar. URX1 indicates the results of using iaIs25[gcy-37p::GFP], and URX2, the results of ynIs78[flp-8p::GFP]. (G) The loss (dashed circle) of DVB fate marker in lem-3(−) mutants. (H) The gain of extra (neuron-like and hypodermis-like) cells labeled by PVR marker and the loss of PVR fate marker in lem-3(−) mutants. (I) The penetrance of the “syn” and “loss” phenotypes for DVB and PVR neurons. DVB1 indicates the results of using oxIs12[unc-48p::GFP], and DVB2, the results of otIs92[flp-10p::GFP]. The data underlying this Figure can be found in S1 Data.

Lastly, since neurogenesis in C. elegans is largely nonclonal, we also analyzed terminal cell divisions that happen to generate one neuron and one nonneuronal sister. For example, the sister cell of the DVB neuron is the rectal cell, and we found that the expression of two DVB markers (unc-47p::GFP and flp-10p::GFP) was both lost in ~5% of the lem-3(−) animals, suggesting that the DVB fate may potentially be suppressed in the syncytium (Fig 7G and 7I). In the case of PVR neuron, whose sister is the hypodermal cell hyp 7, we found both syncytium and fate loss phenotypes with equal penetrance in lem-3(−) mutants. Interestingly, the extra cell connected to PVR in the syncytium appeared to be neuron-like in some animals and hypodermis-like in others based on the morphology (Fig 7H and 7I). This finding hinted that it may be possible to convert skin cells into neurons through direct cytoplasmic coupling, although this conversion was previously demonstrated by overexpressing certain transcription factors [38] or microRNAs [39]. On the other hand, just like the AVM-SDQR syncytium, two cell fates that are as distinct as neuron and skin might co-exist in the same syncytium that links the two cell bodies through an intercellular bridge.

Discussion

In this study, we uncovered a role of the endonuclease LEM-3 in the separation of sister cells during the final round of cell division prior to terminal differentiation and fate specification. The loss of LEM-3 led to unresolved chromatin bridges, which resulted in cytokinesis failure and formation of binucleate syncytia. Based on the separation of the two nuclei, these syncytia exhibit cellular ploidy rather than nuclear ploidy, suggesting successful karyokinesis but failed cytokinesis. This phenotype is consistent with the established function of LEM-3 as a midbody-tethered nuclease that resolves persistent DNA bridges, acting as a “last-chance” mechanism to ensure proper cell abscission [13,40]. However, syncytia found in lem-3(−) mutants are mostly “two-body” syncytia, which have two distinct cell bodies that are connected by an intercellular bridge, instead of the commonly observed “one-body” syncytia, where furrow regression leads to a big cell body that contains two nuclei. Although many factors (e.g., mutations in cytoskeleton regulators, loss of DNA repair factors, kinetochore defects, chromatin linkages) can cause cytokinesis failure and polyploidy [41,42], such “two-body” syncytia were rarely observed. This is likely because most of the previous reports studied cell division using continuously dividing cells (either cells in culture or embryonic cells), whereas we studied the final round of cell division in development. The persistent chromatin bridges in these postmitotic cells appear to neither evoke mechanical resolution nor cause furrow regression. The pause of abscission triggered by the Aurora B-dependent NoCut checkpoint became a permanent state for the two sister cells; then the stretching of the chromatin bridge as the two nuclei move away from each other leads to the formation of the stable cytoplasmic bridge and the “two-body” syncytia. Although the underlying mechanisms for such a phenomenon are not entirely clear, we reason that it may involve the disassembly of the midbody structure and the exit of cell cycle.

The two nuclei in the lem-3(−) syncytia (e.g., AVM-SDQR syncytium) could maintain distinct transcriptional programs despite the nuclear and cytoplasmic connection. This finding is consistent with the results of single-nucleus RNA sequencing and spatial transcriptomic studies on various types of syncytia (including skeletal muscle fibers, placental trophoblasts, and slime mold plasmodia), which also revealed transcriptional heterogeneity driven by positional cues, developmental stages, or environmental stimuli [43–46]. However, the functional consequences at the protein level of this transcriptional heterogeneity are not entirely clear. Our work offers an example to show that proteins translated from the transcripts synthesized in one nuclei can easily diffuse into the entire syncytium with a size of a few hundred micrometers in length. At this scale, the transcriptional diversity of the two nuclei does not lead to protein diversity between the two connected cell bodies. At a larger scale (e.g., muscle fibers can reach tens of centimeters in length), how much protein heterogeneity exists in a single syncytium is unclear but can be understood by detailed spatial proteomic studies with subcellular resolution.

Multinucleated syncytia, in physiological context, can promote the functionality of tissues, such as the heart muscles (cardiomyocyte syncytia), bone marrow (megakaryocytes), and liver (hepatocyte syncytia), by enhancing metabolic capacity and stress resistance [47]. Under pathological conditions, however, polyploidy is linked to blood disorders, female infertility, age-related macular degeneration, and cancers [41,42]. The loss of human ANKLE1 impaired erythrocyte differentiation by the failure in cleaving and degrading mitochondrial DNA [48] and led to polyploidy that renders breast cancer cells in a stem cell-like state [49]. Interestingly, the binucleate syncytia in the lem-3(−) mutants in our study did not revert to a precursor state despite the mixing of the cellular contents of the two sister cells. Instead, in some case (e.g., the AVM-SDQR syncytium), the two connected cells were able to undergo morphological and molecular differentiation to adopt their respective cell shapes and activate a battery of genes associated with their respective fates. This developmental robustness against polyploidy is surprising and suggests that two independent modules control the differentiation of two neuron types (e.g., AVM and SDQR). They do not interfere with each other and can essentially operate in parallel in the syncytium to allow it to develop into a mixed fate.

On the other hand, the ALM-BDU and PLM-ALN syncytia represent a different type of examples, where the fate of one of the sister cells is suppressed and the two nuclei in the syncytium adopt similar transcriptional programs (i.e., the TRN genetic program). A potential reason for the dominance of the TRN fate in the syncytia is that the TRN terminal selector MEC-3 can diffuse into the sister cells through the intercellular bridge and exert a dominant effect to activate the TRN fate and repress the sister cell fate. A previous study showed that MEC-3 has higher affinity to the transcription factor UNC-86 than the BDU fate selector PAG-3 [15]. Thus, the presence of MEC-3 in the BDU not only causes the formation of MEC-3/UNC-86 heterodimer, which activates TRN genes, but also prevents the formation of PAG-3/UNC-86 complex required for the activation of BDU genes. Interestingly, the BDU cell in the ALM-BDU syncytia is only partially converted to the ALM fate (e.g., the expression of BDU marker ceh-14 is maintained), likely due to the moderate level of MEC-3 in BDU. Ectopic overexpression of MEC-3 in BDU can fully transform the morphology and gene expression of BDU into a ALM-like state.

The loss of BDU and ALN fates in lem-3(−) mutants suggests a detrimental effect of cytoplasmic linkage between two sister cells. In fact, many fate specification processes we examined are affected (i.e., loss of marker expression) by mutations in lem-3, although at a low penetrance due to the low frequency of naturally occurring chromatin bridges. Thus, we suspect that many fates are likely vulnerable to a competing fate selector from the sister cell. In this sense, by resolving the chromatin bridges, LEM-3 prevents the formation of binucleate syncytia and safeguards the fate specification process. In addition, lem-3(−) mutants can serve as a tool to study the interaction between the fate-determining programs of two sister cells (e.g., coexistence or dominance of one against another). Given that LEM-3 is an evolutionarily conserved endonuclease and has conserved functions in processing DNA bridges, future work can explore whether its orthologs also play important roles in terminal differentiation in other organisms.

Materials and methods

Strains and constructs

C. elegans strains were maintained at 20 °C on nematode growth medium (NGM) plates seeded with OP50 bacteria according to previous methods [50]. Unless otherwise indicated, the phenotypes of lem-3 mutants were scored at 25 °C, which produced the highest penetrance among the conditions we tested. To generate the lem-3 knockout, we used CRISPR/Cas9-mediated gene editing to make cuts at two sites of the endogenous locus. The target sites are 5′-GTGGTGATTGCTCCGTTTGG-3′ in exon 1 and 5′-AACAATCGACGTGGAGCAGG-3′ in exon 7. We synthesized the single guide RNAs using the EnGen sgRNA Synthesis Kit (E3322V) from NEB and injected them together with 20 pmol recombinant Cas9 (EnGen S. pyogenes Cas9 NLS from NEB, M0646T) into C. elegans using pCFJ104 (myo-3p::mCherry) as a co-injection marker. We genotyped the transformants with red muscles to screen for deletions in lem-3 and obtained unk84 and unk85 alleles. Both alleles deleted the sequence between the two target sites, while unk84 also had a short insertion of 24-bp random sequences (Fig 1A). We used unk84 as the lem-3(−) mutant in most experiments. Similarly, to generate mec-3 null alleles, we targeted the 5′-GTGGACGGCATTTATCACCG-3′ sequence in exon 5 and 5′-TGAGACATTATGAGCAACGT-3′ in exon 7 and obtained unk398, unk400, unk402, and unk403 alleles. Both unk398 and unk403 alleles deleted 2 nucleotides in exon 5 and caused frameshift; unk400 deleted most of exon 5, 6, and 7; unk402 inserted 93 nucleotides in exon 5 and caused premature stops (S4A Fig).

The gt3309(eGFP::Stag::lem-3), gt3310(eGFP::STag::lem-3[S192A S194A]), and gt3311(eGFP::Stag::lem-3[Y556A G558A]) alleles [2] were generously provided by Dr. Anton Gartner and Dr. Ye Hong. To rescue lem-3(−) mutant phenotype, we cloned a 9-kb lem-3 genomic fragment, including 6 kb sequences upstream of the start codon, the coding region, and the 3’UTR, into pUC57 and injected it into the lem-3(unk84) mutants. To create egl-17p::lem-3::GFP, we cloned the lem-3 coding region and fused it to the downstream of a 3.2 kb egl-17 promoter and upstream of GFP coding sequence and an unc-54 3’UTR. The constructs were injected into animals carrying the casIs131[egl-17p::mCherry::zen-4] transgene, which labels the midbody. To label various neuronal fates, we used an array of transgenic fluorescent reporters generated by previous studies and crossed them with the lem-3 mutants. All strains used in this study are listed in S1 Table.

To misexpress mec-3, we cloned a 2,188-bp unc-119 promoter between HindIII and BamHI sites in pPD95.75 and then inserted the mec-3 coding and 3’UTR sequence at the NotI site. The resulting construct was then injected into C. elegans gonad and integrated into the genome to form uIs158[unc-119p::mec-3]. To create transgenes that express proteins with various subcellular localizations under the TRN-specific promoters (e.g., a 1.9-kb mec-17 and a 400-bp mec-18 promoters), we cloned the respective proteins (e.g., dendra2 for photoconvertible fluorescent protein, the PH domain of PLCdelta1 fused with GFP for a membrane protein [51], GFP fusion protein with a nuclear localization signal, the ER chaperone MEC-6 for ER [52], etc.; see S1 Table for details). To label microtubules, we cloned a genomic fragment of maph-1.1 (a homolog for MAP1), including a 3.7-kb promoter, coding region and 1-kb 3’UTR and inserted GFP before the stop codon. To label actin filaments, we fused the LifeAct sequence [30] at the N-terminus of GFP and inserted it downstream of the mec-17 promoter. These constructs were injected into C. elegans gonad to form extrachromosomal arrays, some of which were integrated using gamma irradiation.

smFISH and smiFISH

To monitor transcription of endogenous genes from the two nuclei of the syncytia, we performed single-molecule RNA fluorescent in situ hybridization (smFISH) against TRN-specific genes mec-17, mec-18, and mec-3, and the sister fate-specific genes lad-2, zig-3, ast-1, and D2089.3. To detect transcription of GFP in the syncytia that express the integrated fluorescent fate reporters, we conducted smFISH against GFP. In general, we designed the FISH probes using the Stellaris RNA FISH Probe Designer tool from Biosearch Technologies (Petaluma, CA) and synthesized them with Quasar 670 dye. L1 or L2 stage animals from various strains were fixed, stained with the FISH Probe sets in the hybridization buffer (purchased from Biosearch Technologies), and then washed using the wash buffer based on a previous protocol [53]. The hybridized animals were then mounted using VECTASHIELD Antifade Mounting Medium (Vector Laboratories #H-1000) and imaged using a Leica DM8 microscope with Cy5 filter sets.

We also performed smiFISH (single-molecule inexpensive FISH) [54] against additional TRN sister fate-specific genes, including nlp-20, nlp-80, flp-12, and C15C7.4. smiFISH is a modified version of smFISH in which the primary probe binds to the target mRNA and contains a flap sequence that is bound by a secondary probe which is fluorescently labeled. We designed the primary probes using the Stellaris RNA FISH Probe Designer tool and added the X Flap sequence to the 5′ end of each probe. The X Flap sequence was 5′-CCTCCTAAGTTTCGAGCTGGACTCAGTG-3′. An equimolar mixture of the primary probe set was prepared at 100 μM in IDTE buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 8.0). Secondary probes were the reverse complement of the X Flap sequence and were labeled with Quasar 670 dye at the 5′ end. Both primary and secondary probes were synthesized by Beijing Tsingke Biotech Company Limited. To hybridize the fluorophore-labeled secondary probes to the 5′-extended primary probe sets, an annealing reaction was performed at a final concentration of 20 μM. The reaction mix consisted of 2 μl of 100 μM primary probe mix (200 pmol in total), 2.5 μl of 100 μM secondary probe (250 pmol in total), 1 μl of 10X T4 DNA ligase buffer (NEB), and 4.5 μl of water. The reaction mix was incubated in a thermocycler using the following programs: 95 °C for 3 min, decrease 0.5 °C per cycle and hold for 30 s (59 cycles), 65 °C for 3 min, decrease 0.5 °C per cycle and hold for 30 s (79 cycles), 95 °C for 5 min. Steps for C. elegans sample preparation, hybridization, washing, and image acquisition were the same as those for smFISH. All FISH probes used in this study are listed in S2 Table.

Pharmacological treatments and mcm-7 RNAi

To treat the animals with various drugs, we added ICRF-193 into the NGM plates at 10 μM, Colchicine at 1 mM, Paclitaxel (Taxol) at 100 nM, Y-27632 at 100 nM, and Latrunculin-A at 1 μM.

For mcm-7 RNAi, we obtained the bacteria expressing dsRNA against mcm-7 from the Ahringer C. elegans RNAi feeding library and grew the bacteria at 37 °C until reaching an OD600 of 0.6 and then seeded the bacteria onto NGM plates supplemented with 1 mM IPTG for overnight induction. L4 hermaphrodites were transferred to the RNAi plates and fed at 25 °C. Treating the animals with 100% mcm-7 RNAi bacteria led to sterility, so we mixed mcm-7 RNAi bacteria and OP50 of equal OD600 at 7:93 ratio to make a 7% mcm-7 RNAi bacteria solution and seeded them on the RNAi plates.

Photoactivation and photoablation

Day-one adult worms were immobilized on 10% agarose pads using polystyrene microspheres (Polysciences #00876–15; diluted 6-fold) and high-precision cover glasses (Paul Marienfeld GmbH and Co. KG #0107052). Worms were raised in the dark to avoid unnecessary photoconversion under natural lighting. As a small amount of Dendra2 is activated during worm handling, a Rhodamine fluorescence filter set was used to locate the TRN syncytium by detecting very low levels of red fluorescence. Using the green (546 nm) light to track the TRN syncytium served two purposes: 1) to avoid further depletion of the inactive Dendra2 pool, and 2) to photobleach activated Dendra2 as much as possible before photoconversion. A 405 nm laser was then used to deliver 2 s of blue light at 5% intensity to the TRN cell bodies via a Leica Infinity Scanner powered by a Widefield Compact Supply Unit on a Leica DMi8 microscope equipped with 63x water objectives. The same 405 nm laser was applied to the TRN cell bodies each time when the red fluorescence in the connected sister cells was imaged using 10% intensity of 546 nm light at various intervals. The fluorescent intensity of activated dendra2 was quantified by using imageJ.

To cut the intercellular bridge using a laser, day-one adult animals were similarly immobilized, and 355-nm UV light was delivered to the middle of the bridge through a Pulsed Laser Unit attached to the Infinity Scanner on the Leica DMi8 using 63x water lenses. To minimize injury, the lowest energy that enabled the severing of the bridge was used. Animals were then rescued and placed on NGM plates for recovery and were imaged 24 and 48 hours after the axotomy. The fluorescence in both AVM and SDQR cell bodies was quantified.

Plate dropping assay and gentle touch assay

Both the plate dropping and gentle touch assays were conducted using synchronized day-one adult hermaphrodites. Strains included wild-type animals and lem-3 mutants with AVM-SDQR syncytium. Worms were transferred to the unseeded NGM plate and allowed to acclimate for 2 hours prior to testing. Responses were recorded using a Nikon SMZ745T stereomicroscope equipped with a CTS CWHC-8MB 4K microscope camera at 30 frames per second. The plate dropping assay was adapted from standard protocols to assess mechanosensory responses mediated by TRNs. Plates were subjected to mechanical perturbation by dropping a plate with standardized weight (91–95 g) from a height of 10 cm onto the imaging stage, simulating a vibrational tap to elicit behavioral responses. Each worm was tested individually and experienced 5 drops with a 50-s inter-stimulus interval. Responses were recorded immediately after each drop. Behavioral outcomes were categorized as “Reversal” (backward locomotion), “Acceleration” (forward acceleration), “No response” (continued locomotion without change in velocity), or “Pause” (halted forward movement). A minimum of 8 animals per strain were assayed, with experiments performed in triplicate on independent days.

The gentle-touch assay followed the standard protocol described by Chalfie and colleagues [55]. Gentle touch was applied alternately to the anterior and posterior body regions using eyebrow hair mounted on a glass pipette, with five anterior and five posterior touches per worm, separated by 15-s intervals. Twenty animals were tested and the response of each animal was recorded.

Image acquisition and phenotype scoring

Fluorescent imaging was conducted using a Leica DMi8 inverted microscope outfitted with a Leica K5 monochrome camera. The Leica THUNDER deconvolution system was applied to enhance image clarity and eliminate out-of-focus light in certain images. Image analysis and measurements were carried out using the Leica Application Suite X software. To score the penetrance of syncytium formation, animals were grown at 25 °C for at least two generations and then imaged at day-one adult stage. At least 200 animals from each strain were examined.

Quantification and statistical analysis

All data were plotted as mean ± SD using GraphPad Prism 8.0. For penetrance, three biological replicates were performed and the mean ± SD for the percentage of animals with the phenotype was calculated. For multiple comparisons, we performed one-way ANOVA followed by a Dunnett’s multiple comparisons test (comparison with the wild type) or a Tukey’s honestly significant difference (HSD) test (selected pairwise comparison). Student t test was used to compare only two groups. Single, double, and triple asterisks indicate statistical significance at p < 0.05, < 0.01, and < 0.001, respectively.

Supporting information

S1 Fig. Binucleate syncytia between TRNs and their sister cells in lem-3 mutants.

(A) The TRN-sister cell syncytia in lem-3(unk84) mutants express TRN markers, unkEx309[mec-18p::GFP] and unkEx313[mec-4p::YFP]. Arrows indicate the intercellular bridge of the syncytium. Scale bars = 10 μm. (B) The percentage of TRNs showing the syncytium labeled by various TRN markers, including uIs31[mec-17p::GFP], unkEx309, and unkEx313. (C) Similar morphology of the SDQR neuron in wild-type and lem-3(−) mutants that possess the AVM-SDQR syncytium. (D) The two cell bodies in the AVM-SDQR and PLMR-ALNR syncytia both contain histones labeled by oxTi75[eft-3p::GFP::H2B]. Arrows point to the histone-containing nuclei. “Z1” and “Z2” indicate two focal planes of the same animal. (E) The AVM-SDQR syncytium expresses various SDQR markers, including ynIs25[flp-12p::gfp], ast-1::GFP(vlc19), and otIs358[ser-2p2::GFP]. (F) The PVM-SDQL syncytium is labeled by SDQL markers, flp-12p::GFP and ast-1::GFP. Because ser-2p2p::GFP is expressed in both PVM and SDQL in the wild-type animals, it cannot be used as an SDQL-specific marker for the syncytium. As expected, the PVM-SDQL syncytium shows ser-2p2p::GFP expression. The data underlying this Figure can be found in S1 Data.

(TIF)

S2 Fig. Repression of sister cell fate markers in ALM-BDU and PLM-ALN syncytia.

(A, B) The lack of expression (dashed circles) of BDU fate markers unkEx914[nlp-80p::GFP], unkEx917[C15C7.4p::GFP], and otIs92[flp-10::GFP] in the ALM-BDU syncytium of lem-3(unk84) mutants. The persistent expression of BDU fate markers, wgIs73[ceh-14::EGFP] (circles) and otIs358[ser-2p2::GFP], in the syncytium. Scale bars = 10 μm. “Z1” and “Z2” indicate two focal planes of the same animal. (C) The comparison of morphology of the BDU neurons labeled by otIs358 in the wild-type animals and the BDU of the ALM-BDU syncytium labeled by uIs115[mec-17p::TagRFP] in lem-3(unk84) mutants. (D, E) The absence of expression (dashed circles) of ALN fate markers rtEx332[nlp-20p::GFP], ast-1::GFP(vlc19), and otIs358[ser-2p2::GFP] in the PLM-ALN syncytia. For the case of otIs358[ser-2p2::GFP], two scenarios were shown. One shows only the PLMR-ALNR syncytium and wild-type PLML; the other shows both the PLML-ALNL and the PLMR-ALNR syncytia.

(TIF)

pbio.3004099.s002.tif (9.9MB, tif)
S3 Fig. Misexpression of mec-3 converts BDU and ALN into TRN-like cells.

(A) BDU neurons express the TRN marker uIs115 and do not express the BDU fate markers otIs358[ser-2p2::GFP] and otIs14[zig-3p::GFP] in the animals carrying the uIs158[unc-119p::mec-3] transgene. SDQR expresses the TRN marker but also keeps the expression of the SDQ marker otIs358 upon mec-3 misexpression. Dashed circles indicate the lack of expression. Scale bars = 10 μm. Neuron names with an asterisk mean that the neuron abnormally expresses the TRN marker upon forced expression of mec-3. (B) ALN neurons express the TRN fate marker uIs115[mec-17p::TagRFP] and lose the expression of ALN markers otIs358[ser-2p2::GFP] and uIs130[lad-2p::GFP] in animals carrying the uIs158[unc-119p::mec-3] transgene. Wild-type expression pattern of otIs358[ser-2p2::GFP] in the tail can be found in S2B Fig for comparison. (C) SDQR expresses both the TRN marker uIs115 and the SDQ marker uIs130[lad-2p::GFP] in animals carrying the uIs158 transgene.

(TIF)

pbio.3004099.s003.tif (5.8MB, tif)
S4 Fig. MEC-3 is required for the activation of TRN fate in the sister cells of the TRN-sister syncytia.

(A) Various mec-3 null alleles generated in this study. (B) The loss of TRN fate marker mec-17p::TagRFP in mec-3(unk400) and lem-3(unk84); mec-3(unk398) animals. The ALN-PLM syncytium expressed the ALN marker lad-2p::GFP. (C) The TRN fate marker mec-17p::TagRFP was not expressed in mec-3(unk402) and lem-3(unk84); mec-3(unk403) animals. In both animals, ALM expressed the BDU marker zig-3p::GFP. (D, E) The TRN marker mec-17p::TagRFP was not expressed in mec-3(unk400) and lem-3(unk84); mec-3(unk398) animals. The AVM-SDQR and PVM-SDQL syncytia expressed the SDQ marker lad-2p::GFP. Scale bars, 10 μm.

(TIF)

pbio.3004099.s004.tif (4.9MB, tif)
S5 Fig. Endogenous expression of TRN and sister cell fate markers in wild-type TRNs and sister cells, respectively.

(A–D) smFISH against various cell fate markers was done in wild-type animals carrying the uIs31[mec-17p::GFP] transgene that marks the TRNs. (A) smFISH signals for the mRNAs of TRN genes mec-17, mec-18, and mec-3 in wild-type animals. Dashed orange circles indicate the cell bodies. The uIs31[mec-17p::GFP] transgene was used to label the TRNs. Scale bars = 5 μm. (B) Lack of smFISH signals for SDQ marker genes lad-2, ast-1, and flp-12 in AVM and PVM neurons. SDQR marker ser-2 mRNAs are not found in AVM but are found in 100% (n = 10) of PVM neurons. (C) smFISH signals for BDU fate markers nlp-80, D2089.3, and C15C7.4 are not observed in ALM neurons. ser-2 smFISH signals are found in 62.5% (n = 40) of ALM neurons. (D) smFISH signals for ALN fate markers nlp-20, ast-1, and lad-2 are not found in PLM neurons. ser-2 smFISH signals are found in 60% (n = 40) of PLM neurons. (E–H) smFISH against various cell fate markers was done in wild-type animals carrying the otIs358[ser-2p2::GFP] transgene that marks the sister cells of TRNs. (E) smFISH signals for the TRN fate markers mec-17, mec-18, and mec-3 are not found in the sister cells of TRNs in the wild-type animals. Dashed orange circles indicate the cell bodies. Scale bars = 5 μm. (F) smFISH signals for the SDQ marker genes lad-2, ast-1, and flp-12 in SDQL/R neurons. ser-2 only serves as a SDQR marker, although its mRNAs are found in both SDQL and SDQR. (G) smFISH signals for BDU fate markers nlp-80, D2089.3, C15C7.4, and ser-2 in BDUL/R neurons. (H) smFISH signals for ALN fate markers nlp-20, ast-1, lad-2, and ser-2 in ALNL/R neurons.

(TIF)

pbio.3004099.s005.tif (16.2MB, tif)
S6 Fig. Additional evidence for the activation of endogenous fate markers in the two cell bodies of the syncytia.

(A) smFISH signals for the mRNAs of TRN genes (mec-17, mec-18, and mec-3) and SDQL genes (lad-2, ast-1, and flp-12) in the two cell bodies of the PVM-SDQL syncytia in lem-3(unk84) mutants (n ≥ 10). Dashed circles indicate the cell bodies. “Z1” and “Z2” indicate different focal planes of the same animal. Arrows point to the intercellular bridge. Scale bars = 5 μm. (B) ser-2 smFISH signals are absent in the BDU cell body for 13% of the ALM-BDU syncytia (n = 15). (C) ser-2 smFISH signals are absent in the ALN cell body for 38% of the PLM-ALN syncytia (n = 21). (D) smFISH signals for GFP mRNAs in the lem-3(unk84); uIs31[mec-17p::GFP] strain with the percentage of cells having the shown smFISH staining patterns (n ≥ 10).

(TIF)

pbio.3004099.s006.tif (6.7MB, tif)
S7 Fig. The intercellular bridge enables the exchange of cytoplasmic content between the TRNs and their sister cells in the syncytia.

(A) Photoconversion of dendra2 in the ALM cell body of the ALM-BDU syncytium led to the increase of red fluorescence in BDU neuron (dashed circle). The times indicate the time points after photoconversion. Scale bars = 5 μm. (B) Quantification of the red fluorescence in both ALM and BDU cell bodies throughout the course of the photoconversion experiment. (C, D) After the connection between ALM and BDU cell bodies was cut using a laser, the photoconversion of dendra2 in ALM no longer caused the increase of red fluorescence in BDU neuron. (E, F) After cutting the intercellular bridge between AVM and SDQR, photoconversion of dendra2 in AVM did not lead to the increase of red fluorescence in SDQR. lem-3(unk84); unkEx271[mec-17p::dendra2] was used in these experiments. The data underlying this Figure can be found in S1 Data.

(TIF)

pbio.3004099.s007.tif (1.9MB, tif)
S8 Fig. Intercellular bridge and nuclear envelope connection in the TRN-sister cell syncytia are maintained throughout development and aging.

(A) Quantification of the distance between the two nuclei of the AVM-SDQR syncytia at different developmental stages. lem-3(unk84); uIs115[mec-17p::RFP]; ccIs4810[lmn-1p::lmn-1::GFP] was used to label both the cytosol and nuclear envelope. The syncytia with nuclear envelope (NE) links were marked in red in the plot. (B) Representative images of syncytia with a long NE link or with unseparated nuclei at 72 hours post L1 arrest recovery are shown. Scale bars = 10 μm. (C) Intercellular bridge (arrows) of ALM-BDU and AVM-SDQR syncytia at the day 5 adult stage in lem-3(unk84) mutants. The data underlying this Figure can be found in S1 Data.

(TIF)

pbio.3004099.s008.tif (2.9MB, tif)
S9 Fig. Formation of syncytia between neurons and their apoptotic sisters and between pairs of sister cells in lem-3(−) mutants.

(A) The sister cell of PVDL/R is apoptotic. In the lem-3(unk84); wyIs592[ser-2p3::myr::GFP] animals, which labels the PVD neuron, both syncytia of PVD with an extra cell (“syn”) and the loss of PVD labeling (“loss”) are found. For the former phenotype, arrows point to the bridge and for the latter phenotype, a dashed circle indicates the absence of GFP signal. Scale bars = 5 μm. “Z1” and “Z2” indicate different focal planes of the same animal. (B) The syncytia and the loss of fate marker phenotypes for NSM neurons in the lem-3(−) mutants. (C–G) Representative images of syncytia (“syn”) and fate marker loss (“loss” and dashed circles) phenotypes for URXL/R, ADFL/R, AIYL/R, FLPL/R, and HSNL/R neurons in lem-3(unk84) mutants. In syncytia, sister cells abnormally expressing markers are labeled with yellow names; arrows indicate the intercellular bridge. Quantification of penetrance is shown in Fig 7F. (H) The syncytium phenotype for the RIS neuron in lem-3(unk84) mutants treated with 10 μM ICRF-193.

(TIF)

pbio.3004099.s009.tif (5.5MB, tif)
S1 Table. Strains, constructs, and primers used in this study.

(XLSX)

pbio.3004099.s010.xlsx (13.8KB, xlsx)
S2 Table. smFISH probe sets used in this study.

(XLSX)

pbio.3004099.s011.xlsx (28.5KB, xlsx)
S1 Data. Numeric data underlying all main and supporting figures.

(XLSX)

pbio.3004099.s012.xlsx (20.1KB, xlsx)

Acknowledgments

We thank Prof. Anton Gartner at the Ulsan National Institute for Science and Technology for providing strains and Prof. Gary YW Chan at HKU for insightful discussion. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440).

Abbreviations

hpt

hour post telophase

HSD

honestly significant difference

NE

nuclear envelope

NGM

nematode growth medium

NIH

National Institutes of Health

smFISH

single-molecule fluorescence in situ hybridization

TRNs

touch receptor neurons

WT

wild-type.

Data Availability

All data for this study are available within the paper and its Supporting information files. All individual numerical values underlying the figures are provided in the Supporting information file S1 Data.

Funding Statement

This work was supported by the National Natural Science Foundation of China (https://www.nsfc.gov.cn/, Excellent Young Scientists Fund for Hong Kong and Macau, 32122002 to C.Z.), and the Research Grants Council of Hong Kong (https://www.ugc.edu.hk/eng/rgc/, GRF 17105523, GRF 17106322, GRF 17113324, and GRF 17107325 to C.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Dittrich CM, Kratz K, Sendoel A, Gruenbaum Y, Jiricny J, Hengartner MO. LEM-3 - A LEM domain containing nuclease involved in the DNA damage response in C. elegans. PLoS One. 2012;7(2):e24555. doi: 10.1371/journal.pone.0024555 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hong Y, Sonneville R, Wang B, Scheidt V, Meier B, Woglar A, et al. LEM-3 is a midbody-tethered DNA nuclease that resolves chromatin bridges during late mitosis. Nat Commun. 2018;9(1):728. doi: 10.1038/s41467-018-03135-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Song J, Freeman ADJ, Knebel A, Gartner A, Lilley DMJ. Human ANKLE1 Is a nuclease specific for branched DNA. J Mol Biol. 2020;432(21):5825–34. doi: 10.1016/j.jmb.2020.08.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Song J, Geary P, Salemova K, Rouse J, Hong Y, Rolland SGM, et al. Functional dissection of the conserved C. elegans LEM-3/ANKLE1 nuclease reveals a crucial requirement for the LEM-like and GIY-YIG domains for DNA bridge processing. Nucleic Acids Res. 2025;53(6):gkaf265. doi: 10.1093/nar/gkaf265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jiang H, Kong N, Liu Z, West SC, Chan YW. Human endonuclease ANKLE1 localizes at the midbody and processes chromatin bridges to prevent DNA damage and cGAS-STING activation. Adv Sci (Weinh). 2023;10(12):e2204388. doi: 10.1002/advs.202204388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Steigemann P, Wurzenberger C, Schmitz MHA, Held M, Guizetti J, Maar S, et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell. 2009;136(3):473–84. doi: 10.1016/j.cell.2008.12.020 [DOI] [PubMed] [Google Scholar]
  • 7.Carlton JG, Caballe A, Agromayor M, Kloc M, Martin-Serrano J. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science. 2012;336(6078):220–5. doi: 10.1126/science.1217180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Umbreit NT, Zhang C-Z, Lynch LD, Blaine LJ, Cheng AM, Tourdot R, et al. Mechanisms generating cancer genome complexity from a single cell division error. Science. 2020;368(6488):eaba0712. doi: 10.1126/science.aba0712 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shemer G, Podbilewicz B. Fusomorphogenesis: cell fusion in organ formation. Dev Dyn. 2000;218(1):30–51. doi: 10.1002/(SICI)1097-0177(200005)218:1<30::AID-DVDY4>3.0.CO;2-W [DOI] [PubMed] [Google Scholar]
  • 10.Bauer J, Poupart V, Goupil E, Nguyen KCQ, Hall DH, Labbé J-C. The initial expansion of the C. elegans syncytial germ line is coupled to incomplete primordial germ cell cytokinesis. Development. 2021;148(18):dev199633. doi: 10.1242/dev.199633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Goupil E, Amini R, Hall DH, Labbé J-C. Actomyosin contractility regulators stabilize the cytoplasmic bridge between the two primordial germ cells during Caenorhabditis elegans embryogenesis. Mol Biol Cell. 2017;28(26):3789–800. doi: 10.1091/mbc.E17-08-0502 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hong Y, Velkova M, Silva N, Jagut M, Scheidt V, Labib K, et al. The conserved LEM-3/Ankle1 nuclease is involved in the combinatorial regulation of meiotic recombination repair and chromosome segregation in Caenorhabditis elegans. PLoS Genet. 2018;14(6):e1007453. doi: 10.1371/journal.pgen.1007453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hong Y, Zhang H, Gartner A. The last chance saloon. Front Cell Dev Biol. 2021;9:671297. doi: 10.3389/fcell.2021.671297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Way JC, Chalfie M. mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans. Cell. 1988;54(1):5–16. doi: 10.1016/0092-8674(88)90174-2 [DOI] [PubMed] [Google Scholar]
  • 15.Gordon PM, Hobert O. A competition mechanism for a homeotic neuron identity transformation in C. elegans. Dev Cell. 2015;34(2):206–19. doi: 10.1016/j.devcel.2015.04.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tursun B, Patel T, Kratsios P, Hobert O. Direct conversion of C. elegans germ cells into specific neuron types. Science. 2011;331(6015):304–8. doi: 10.1126/science.1199082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Patel T, Tursun B, Rahe DP, Hobert O. Removal of polycomb repressive complex 2 makes C. elegans germ cells susceptible to direct conversion into specific somatic cell types. Cell Rep. 2012;2(5):1178–86. doi: 10.1016/j.celrep.2012.09.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wang Y, Guan J, Wang H, Wang Y, Leeper D, Iliakis G. Regulation of DNA replication after heat shock by replication protein a-nucleolin interactions. J Biol Chem. 2001;276(23):20579–88. doi: 10.1074/jbc.M100874200 [DOI] [PubMed] [Google Scholar]
  • 19.De Jaeger-Braet J, Schnittger A. Heating up meiosis - chromosome recombination and segregation under high temperatures. Curr Opin Plant Biol. 2024;80:102548. doi: 10.1016/j.pbi.2024.102548 [DOI] [PubMed] [Google Scholar]
  • 20.Evans WE, Parry JM. The genetic effects of elevated temperature in the yeast, Saccharomyces cerevisiae. Heredity (Edinb). 1975;35(3):347–59. doi: 10.1038/hdy.1975.105 [DOI] [PubMed] [Google Scholar]
  • 21.Nielsen CF, Huttner D, Bizard AH, Hirano S, Li T-N, Palmai-Pallag T, et al. PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis. Nat Commun. 2015;6:8962. doi: 10.1038/ncomms9962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Clarke DJ, Johnson RT, Downes CS. Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J Cell Sci. 1993;105 (Pt 2):563–9. doi: 10.1242/jcs.105.2.563 [DOI] [PubMed] [Google Scholar]
  • 23.Liu J, Rolef Ben-Shahar T, Riemer D, Treinin M, Spann P, Weber K, et al. Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes. Mol Biol Cell. 2000;11(11):3937–47. doi: 10.1091/mbc.11.11.3937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lee KK, Gruenbaum Y, Spann P, Liu J, Wilson KL. C. elegans nuclear envelope proteins emerin, MAN1, lamin, and nucleoporins reveal unique timing of nuclear envelope breakdown during mitosis. Mol Biol Cell. 2000;11(9):3089–99. doi: 10.1091/mbc.11.9.3089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fu H, Martin MM, Regairaz M, Huang L, You Y, Lin C-M, et al. The DNA repair endonuclease Mus81 facilitates fast DNA replication in the absence of exogenous damage. Nat Commun. 2015;6:6746. doi: 10.1038/ncomms7746 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Agostinho A, Meier B, Sonneville R, Jagut M, Woglar A, Blow J, et al. Combinatorial regulation of meiotic holliday junction resolution in C. elegans by HIM-6 (BLM) helicase, SLX-4, and the SLX-1, MUS-81 and XPF-1 nucleases. PLoS Genet. 2013;9(7):e1003591. doi: 10.1371/journal.pgen.1003591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. Nucleic Acids Res. 2002;30(17):3848–56. doi: 10.1093/nar/gkf479 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Raich WB, Moran AN, Rothman JH, Hardin J. Cytokinesis and midzone microtubule organization in Caenorhabditis elegans require the kinesin-like protein ZEN-4. Mol Biol Cell. 1998;9(8):2037–49. doi: 10.1091/mbc.9.8.2037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Waaijers S, Muñoz J, Berends C, Ramalho JJ, Goerdayal SS, Low TY, et al. A tissue-specific protein purification approach in Caenorhabditis elegans identifies novel interaction partners of DLG-1/Discs large. BMC Biol. 2016;14:66. doi: 10.1186/s12915-016-0286-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, Bista M, et al. Lifeact: a versatile marker to visualize F-actin. Nat Methods. 2008;5(7):605–7. doi: 10.1038/nmeth.1220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yoshizaki H, Ohba Y, Parrini M-C, Dulyaninova NG, Bresnick AR, Mochizuki N, et al. Cell type-specific regulation of RhoA activity during cytokinesis. J Biol Chem. 2004;279(43):44756–62. doi: 10.1074/jbc.M402292200 [DOI] [PubMed] [Google Scholar]
  • 32.Chalfie M, Sulston JE, White JG, Southgate E, Thomson JN, Brenner S. The neural circuit for touch sensitivity in Caenorhabditis elegans. J Neurosci. 1985;5(4):956–64. doi: 10.1523/JNEUROSCI.05-04-00956.1985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.He H, Fong EKH, Kumar S, Lee HMT, Leifer AM, Chalfie M, et al. Synaptic and neural pathway redundancy enables the robustness of a sensory-motor reflex and promotes predation escape in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2026;123(22):e2531407123. doi: 10.1073/pnas.2531407123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chiba CM, Rankin CH. A developmental analysis of spontaneous and reflexive reversals in the nematode Caenorhabditis elegans. J Neurobiol. 1990;21(4):543–54. doi: 10.1002/neu.480210403 [DOI] [PubMed] [Google Scholar]
  • 35.Almoril-Porras A, Calvo AC, Niu L, Beagan J, Díaz García M, Hawk JD, et al. Configuration of electrical synapses filters sensory information to drive behavioral choices. Cell. 2025;188(1):89-103.e13. doi: 10.1016/j.cell.2024.11.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Middelkoop TC, Korswagen HC. Development and migration of the C. elegans Q neuroblasts and their descendants. WormBook. 2014;:1–23. doi: 10.1895/wormbook.1.173.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Vasilev F, Mihajlović AI, Rémillard-Labrosse G, FitzHarris G. Long-lived cytokinetic bridges coordinate sister-cell elimination in mouse embryos. Dev Cell. 2025;60(11):1521-1531.e5. doi: 10.1016/j.devcel.2025.01.002 [DOI] [PubMed] [Google Scholar]
  • 38.Caiazzo M, Dell’Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature. 2011;476(7359):224–7. doi: 10.1038/nature10284 [DOI] [PubMed] [Google Scholar]
  • 39.Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011;476(7359):228–31. doi: 10.1038/nature10323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hong Y, Sonneville R, Wang B, Scheidt V, Meier B, Woglar A, et al. LEM-3 is a midbody-tethered DNA nuclease that resolves chromatin bridges during late mitosis. Nat Commun. 2018;9(1):728. doi: 10.1038/s41467-018-03135-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Lens SMA, Medema RH. Cytokinesis defects and cancer. Nat Rev Cancer. 2019;19(1):32–45. doi: 10.1038/s41568-018-0084-6 [DOI] [PubMed] [Google Scholar]
  • 42.Conway PJ, Dao J, Kovalskyy D, Mahadevan D, Dray E. Polyploidy in cancer: causal mechanisms, cancer-specific consequences, and emerging treatments. Mol Cancer Ther. 2024;23(5):638–47. doi: 10.1158/1535-7163.MCT-23-0578 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Admati I, Skarbianskis N, Hochgerner H, Ophir O, Yagel S, Solt I, et al. Single-nuclei RNA-sequencing fails to detect molecular dysregulation in the preeclamptic placenta. Placenta. 2025;159:170–9. doi: 10.1016/j.placenta.2024.12.011 [DOI] [PubMed] [Google Scholar]
  • 44.Gerber T, Loureiro C, Schramma N, Chen S, Jain A, Weber A, et al. Spatial transcriptomic and single-nucleus analysis reveals heterogeneity in a gigantic single-celled syncytium. Elife. 2022;11:e69745. doi: 10.7554/eLife.69745 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kim M, Franke V, Brandt B, Lowenstein ED, Schöwel V, Spuler S, et al. Single-nucleus transcriptomics reveals functional compartmentalization in syncytial skeletal muscle cells. Nat Commun. 2020;11(1):6375. doi: 10.1038/s41467-020-20064-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bataillé L, Boukhatmi H, Frendo J-L, Vincent A. Dynamics of transcriptional (re)-programming of syncytial nuclei in developing muscles. BMC Biol. 2017;15(1):48. doi: 10.1186/s12915-017-0386-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lacroix B, Maddox AS. Cytokinesis, ploidy and aneuploidy. J Pathol. 2012;226(2):338–51. doi: 10.1002/path.3013 [DOI] [PubMed] [Google Scholar]
  • 48.Przanowski P, Przanowska RK, Guertin MJ. ANKLE1 cleaves mitochondrial DNA and contributes to cancer risk by promoting apoptosis resistance and metabolic dysregulation. Commun Biol. 2023;6(1):231. doi: 10.1038/s42003-023-04611-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.McKenzie C, D’Avino PP. Investigating cytokinesis failure as a strategy in cancer therapy. Oncotarget. 2016;7(52):87323–41. doi: 10.18632/oncotarget.13556 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. doi: 10.1093/genetics/77.1.71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Garcia P, Gupta R, Shah S, Morris AJ, Rudge SA, Scarlata S, et al. The pleckstrin homology domain of phospholipase C-delta 1 binds with high affinity to phosphatidylinositol 4,5-bisphosphate in bilayer membranes. Biochemistry. 1995;34(49):16228–34. doi: 10.1021/bi00049a039 [DOI] [PubMed] [Google Scholar]
  • 52.Chen Y, Bharill S, Altun Z, O’Hagan R, Coblitz B, Isacoff EY, et al. Caenorhabditis elegans paraoxonase-like proteins control the functional expression of DEG/ENaC mechanosensory proteins. Mol Biol Cell. 2016;27(8):1272–85. doi: 10.1091/mbc.E15-08-0561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Topalidou I, van Oudenaarden A, Chalfie M. Caenorhabditis elegans aristaless/Arx gene alr-1 restricts variable gene expression. Proc Natl Acad Sci U S A. 2011;108(10):4063–8. doi: 10.1073/pnas.1101329108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Tsanov N, Samacoits A, Chouaib R, Traboulsi A-M, Gostan T, Weber C, et al. smiFISH and FISH-quant - a flexible single RNA detection approach with super-resolution capability. Nucleic Acids Res. 2016;44(22):e165. doi: 10.1093/nar/gkw784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Chalfie M. Assaying mechanosensation. WormBook. 2014;:1–13. doi: 10.1895/wormbook.1.172.1 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ines Alvarez-Garcia

20 Mar 2026

Dear Dr Zheng,

Thank you for submitting your manuscript entitled "LEM-3/ANKLE1 nuclease prevents the formation of syncytium between postmitotic sister cells and safeguards neuronal differentiation" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Mar 24 2026 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Decision Letter 1

Ines Alvarez-Garcia

28 Apr 2026

Dear Dr Zheng,

Thank you for your patience while your manuscript entitled "LEM-3/ANKLE1 nuclease prevents the formation of syncytium between postmitotic sister cells and safeguards neuronal differentiation" was peer-reviewed at PLOS Biology. The manuscript has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers.

The reviews are attached below. As you will see, the reviewers find the results interesting, but they also raise several issues that would need to be addressed before we can consider the manuscript for publication. Reviewer 1 raises several issues in the figures, including clarifications and an alternative interpretation of the observation on proteins diffused via the canal between the two sister cells. Reviewer 2 disagrees with the conclusion that the fate change in TRN sister cells is due to MEC-3 diffusion, and thinks that it should be shown that MEC-3 is functionally competent. In addition, this reviewer thinks it should be tested if the fate change phenotype is inhibited by the loss of MEC-3 to confirm that the presence of MEC-3 is needed for the fate change. Reviewer 3 mentions that the localisation of the LEM-3 recruitment to the midbody in embryos during the division that produces TRNs and their sister cells should be analysed, and also requests missing controls and clarifications.

In light of the reviews, we would like to invite you to revise the work to thoroughly address the reviewers' reports. Given the extent of revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by all or a subset of the reviewers.

In addition to these revisions, you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly.

We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type.

3. Resubmission Checklist

When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision and fulfil the editorial requests:

a) *PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). Please also indicate in each figure legend where the data can be found. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

b) *Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

c) *Blot and Gel Data Policy*

Please provide the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

d) *Blurb*

Please also provide a blurb which (if accepted) will be included in our weekly and monthly Electronic Table of Contents, sent out to readers of PLOS Biology, and may be used to promote your article in social media. The blurb should be about 30-40 words long and is subject to editorial changes. It should, without exaggeration, entice people to read your manuscript. It should not be redundant with the title and should not contain acronyms or abbreviations. For examples, view our author guidelines: https://journals.plos.org/plosbiology/s/revising-your-manuscript#loc-blurb

e) *Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

------------------------------------

Reviewers' comments

Rev. 1:

This study identified a function for the C. elegans endonuclease LEM-3 in the separation of sister cells during the final cell division preceding terminal differentiation and fate determination. When LEM-3 is absent, chromatin bridges remain unresolved, leading to failed cytokinesis and the development of binucleate syncytia, evident by a "canal" remaining between sister cells. The failure to separate sister cells during cytokinesis impacts cell neuronal differentiation, resulting in sister cells in some cases acquiring the same cell fate. In some cases where the sibling cell fate is apoptosis, lem-3 mutants showed a loss of apoptosis. Studies of fluorescently labelled cell fate markers and cell fate determinants indicate that these proteins may diffuse in the canal. The results are mostly convincing, and the manuscript is well-written. However, although their study provides detailed explanations to the duplication of sister cell fate in cytokinesis mutants, one could argue that the findings are not surprising and do not in themselves point to a novel general principle in developmental biology.

Major issues

Figure 1: they refer to the connections between sister cell in lem3 mutants as "canals". But could instead be axon/dendrite projections between the cells. What is the difference between a "canal" and an aberrant axon/dendrite?

Figure 2: I find the labelling in the figure confusing. Are all these images from a lem-3 mutant background? How do they score that there is a syncytium? According to Figure 1, the "canal" is only formed in ~20% of cases.

Figure 3: The diffusion of proteins through the canal between the two sister cells is open for other interpretations. For instance, the presence of MEC3::GFP in both sister cells does not automatically mean that MEC3::GFP protein has diffused through the canal. Instead, the diffusion of other proteins may trigger the same cell fate in both sister cells and hence result in the expression of many cell fate markers. To definitively claim that MEC3::GFP and other proteins diffuse through the canal they would have to activate the reporter protein expressions at a later stage and study its diffusion.

Minor issues

Introduction, 1st paragraph: The "final round of cell division…" is over-simplified. In general terms, when introducing the topic and referring to many biological settings, it can come in several very different forms: 1) both sister cells differentiating, and into different fates, 2) both sister cells differentiating, but into the same fate, or 3) one cell differentiating, often referred to as the "daughter cell", while the other, the "mother cell" retains some level of progenitor properties and continues dividing.

Should not unk14 and unk85 be unc-14 and unc-85?

Rev. 2:

The manuscript by Deng and Zheng reports the characterization neuronal fate specification in animals lacking the function of LEM-3, a midbody-localized nuclease. The authors uncovered an allele of lem-3 in a screen for extra touch receptor neurons (TRNs). They show that these mutants maintain a stable cytoplasmic bridge (which they call intercellular canal) between TRNs and their sister cells. The bridge contains actin, tubulin and DNA/chromatin and enables cytoplasmic exchange between sister cells. The authors demonstrate that the bridge correlates with a proportion of sister cells adopting a TRN fate, likely due to the diffusion of TRN-promoting factors, including MEC-3. The authors propose that the presence of chromatin bridges, which are typically processed by LEM-3, results in the long-term stabilization of the intercellular bridge in terminally-differentiating neurons and that this impacts neuronal fates by enabling the exchange of proteins between the two sister cells.

Overall I find the manuscript to be of excellent quality, with a sound experimental design and original findings that should be of interest to neurobiologists and cell biologists alike. The main finding that chromatin bridges can result in the stabilization of the intercellular bridge in cells undergoing terminal division prior to differentiation is novel, and the authors convincingly show that this bridge enables the sharing of cytoplasmic constituents, and thus can have an impact on cell fate. I have a few suggestions that the authors should consider to improve the quality of their work.

My main suggestion is in regards to lines 133-149, where the authors postulate that the fate change in TRN sister cells is due to diffusion of the TRN fate specifying factor MEC-3. They seek to test this idea by showing that ectopic expression of MEC-3 is sufficient to induce a fate change, however I do not think that this ectopic expression really tests their idea. I understand that part of the idea is that molecules can diffuse through the stable canal, including MEC-3 itself (as shown in Figure 3), however this does not show that MEC-3 is functionally competent. I think that the simplest way to show that the fate change is due to the presence of MEC-3 is to test whether the fate change phenotype is suppressed by the loss of MEC-3. Of course such gross perturbation will not demonstrate that it is the MEC-3 present in the TNR cell that induces the fate change in its sister, however it should unambiguously assess whether the presence of MEC-3 is needed for this fate change. I think that this functional assessment is important given that the authors take for granted (in this and subsequent sections) that their fate change phenotype is caused by MEC-3 diffusion.

Minor suggestions and concerns

The authors refer to the connection as an intercellular canal, but this is a somewhat novel term that does not serve to anchor their work in biology. When cells divide they form a transient intercellular bridge around a midbody, and abscission leads to the severing of the bridge (membrane scission) and release of the midbody. In certain cells that undergo incomplete cytokinesis (e.g. germ cells), the intercellular bridge is stabilized, thus forming a stable intercellular bridge. I suggest that the authors employ the term stable intercellular bridge (or stable cytoplasmic bridge) instead of intercellular canal to better anchor their finding into the existing work on these structures.

I wonder whether the term syncytium is appropriate to refer to cells that remain connected by a stable bridge as a result of cytokinesis failure. My understanding of syncytia is that they can be generated by incomplete cytokinesis but this is a programed feature that is highly regulated, which is not the case here. They can also arise of pathological conditions (e.g. viral infections) but it is also different than what is observed here. I understand why the authors equate their cell pairs to syncytia but my opinion is that the term is not employed appropriately in this context. I suggest to refer to stably connected sister cells rather than syncytial cells.

Lines 60-61: As far as I know, whether the entire C. elegans germline is formed as a result of incomplete cytokinesis is still an open question. Previous work has shown that the germline founder cell undergoes incomplete cytokinesis (PMID: 29074566) and that the first division of the PGCs may be incomplete (PMID: 34195824), however the notion that there is a sustained incomplete cytokinesis program when the germline expands remains hypothetical and some work suggests other mechanisms. The authors could instead write that "the germline of C. elegans hermaphrodites arises via incomplete cytokinesis and forms a syncytium in which more than 1000 nuclei share cytoplasm through stable bridges".

Line 70: define TRN (touch receptor neuron) in this sentence.

Line 77, "…we mapped unk14 to the V618M mutation in lem-3…": Please rewrite. V618M is an amino acid change, not a mutation that can be mapped. The allele mapped to a change at the nucleotide level, which results in a V618M change in the resulting protein.

Lines 209-213 and Figure 3D: I find that the experiment to demonstrate that the stable canal is needed for cytoplasmic exchange is somewhat convoluted. The authors show that if they sever the canal they see a decrease in converted Dendra2 levels in the non-TNR sister, but this occurs over 48 hours. Have the authors considered performing the photoconversion in animals in which the canal has already been cut (i.e. essentially doing the same experiment as in 3B but after the canal is cut)? It seems like this would be more direct to demonstrate that the canal enables cytoplasmic exchange.

Lines 378-381 and Figure 6I: The authors report that inhibiting ced-3 (which blocks apoptosis) results in an increase in the surviving sister cell in cell pairs where one usually dies. I think that it would rather be more informative if the authors documented whether the decrease in 3-cell body syncytia that they reported in older animals (Figure 6E) is suppressed in ced-3 mutants. If this were the case it would support their claim that apoptosis is delayed in 3-cell syncytia.

Rev. 3:

Deng et al. utilize C. elegans as an experimental system to investigate how the failed cytokinesis affect the specification of postmitotic neuron cells. They found that the loss of LEM-3 endonuclease, which is responsible for chromatin bridges resolution during cytokinesis, leads to binucleate syncytia connecting TRNs and sister cells through intercellular canal. These intercellular canals allow the diffusion of cytoplasmic proteins, while the transcriptomes of the linked cells can be independently regulated. They further investigated the functional consequences of these connections and found that the cytoplasmic linkages between sister cells resulted in suppression of neuronal fates and prevention of apoptotic fates. Finally, they showed that LEM-3 has a general role in cell fate specification in the nervous system by resolving the chromatin bridges.

In general, this is a very exciting study that provides insight into the consequence of compromised cytokinesis in cell fate differentiation. The experiments are overall well executed, the results are clearly presented.

Major points:

1. While previous studies have shown LEM-3 recruitment to the midbody in embryos, its localization should also be examined in the division that produces TRNs and their sister cells.

2. Fig 1E. The authors should discuss the potential reasons for the significant variation in syncytium penetrance among different TRN subtypes.

3. Fig. 3 shows that proteins, but not mRNAs, diffuse freely throughout the syncytium. Could it be that mRNAs are degraded in the canal or actively blocked by a selective barrier?

4. Fig. 4A The analysis should be complemented by a control experiment demonstrating syncytium formation in wild-type worms treated with the DNA topoisomerase II inhibitor or subjected to mcm-7 RNAi.

5. Fig 6E shows that although the three cells are connected by intercellular canals, only the third cell can be removed without triggering programmed cell death in the entire syncytium. Given that cytoplasmic proteins can diffuse throughout the syncytium, it would be interesting to investigate whether the other two cells could also be labeled by an apoptotic marker such as CED-1::GFP.

Minor points:

1. The abbreviation "TRN" should be spelled out as "touch receptor neuron (TRN)" upon its first use in the manuscript.

2.line 122 Fig. 1B does not seem relevant to this specific point. The supporting data appears to be in Fig.S2 A-B only.

3. Please indicate how the "~20%" value was quantified and where the data is presented. It is not evident in the current Fig. 4E. Also, statistical analysis is required for the quantitative data in Fig 4E.

4. Please add the figure citation (Fig. 5D) to the sentence on lines 307-311 regarding drug treatments.

Decision Letter 2

Ines Alvarez-Garcia

9 Oct 2026

Dear Dr Zheng,

Thank you for your patience while we considered your revised manuscript entitled "LEM-3/ANKLE1 nuclease prevents the formation of abnormal syncytium between postmitotic sister cells and safeguards neuronal differentiation" for publication as a Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors, the Academic Editor and two of the original reviewers.

Based on the reviews (attached below), we are likely to accept this manuscript for publication, provided you satisfactorily address the data and other policy-related requests stated below my signature.

In addition, we would like you to consider a suggestion to improve the title:

"LEM-3/ANKLE1 nuclease prevents the formation of abnormal syncytium to safeguard neuronal differentiation"

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

In addition to these revisions, you may need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly. If you do not receive a separate email within a few days, please assume that checks have been completed, and no additional changes are required.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable, if not applicable please do not delete your existing 'Response to Reviewers' file.)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://plos.org/published-peer-review-history/

*Press*

Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

------------------------------------------------------------------------

DATA POLICY: IMPORTANT - PLEASE READ

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Fig. 1E; Fig. 3C, E; Fig. 4A, B, E, F, G, H; Fig. 5E, F; Fig. 6E, H, I; Fig. 7F, I; Fig. S1B; Fig. S7B, D, F and Fig. S8A

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on WHERE THE UNDERLYING DATA CAN BE FOUND, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

------------------------------------------------------------------------

CODE POLICY

Per journal policy, if you have generated any custom code during the course of this investigation, please make it available without restrictions. Please ensure that the code is sufficiently well documented and reusable, and that your Data Statement in the Editorial Manager submission system accurately describes where your code can be found. More information on our Code Policy, what and how to share can be found here: https://journals.plos.org/plosbiology/s/code-availability

Please note that we cannot accept sole deposition of code in GitHub, as this could be changed after publication. However, you can archive this version of your publicly available GitHub code to Zenodo. Once you do this, it will generate a DOI number, which you will need to provide in the Data Accessibility Statement (you are welcome to also provide the GitHub access information). See the process for doing this here: https://docs.github.com/en/repositories/archiving-a-github-repository/referencing-and-citing-content

------------------------------------------------------------------------

Reviewers' comments

Rev. 2:

I consider the revised manuscript by Deng and Zheng as significantly improved compared to the previous version. The authors have done an excellent job to address all reviewers' comments, both editorially and experimentally. The work is of excellent quality and it makes a significant contribution to our understanding of terminal neuronal cell differentiation during development, particularly in the context of cytokinesis failure induced by chromatin bridges.

Rev. 3: Ye Hong - please note that this reviewer has signed the review.

The authors have addressed most of my concerns satisfactorily. Additional experiments and data largely support their conclusions. Regarding my point 3, the authors did not directly address whether mRNAs are degraded in the canal or actively blocked by a selective barrier, but this is a technically challenging question and remains open for future investigation. Overall, all other points have been adequately addressed and the revised manuscript has been improved significantly. I recommend acceptance of this manuscript for publication.

Decision Letter 3

Ines Alvarez-Garcia

23 Oct 2026

Dear Dr Zheng,

Thank you for the submission of your revised Research Article entitled "LEM-3/ANKLE1 nuclease prevents the formation of abnormal syncytium to safeguard neuronal differentiation" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, François Schweisguth, I am delighted to let you know that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Many congratulations and thanks again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study.

Sincerely,

Ines

--

Ines Alvarez-Garcia, PhD

Senior Editor

PLOS Biology

ialvarez-garcia@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Binucleate syncytia between TRNs and their sister cells in lem-3 mutants.

    (A) The TRN-sister cell syncytia in lem-3(unk84) mutants express TRN markers, unkEx309[mec-18p::GFP] and unkEx313[mec-4p::YFP]. Arrows indicate the intercellular bridge of the syncytium. Scale bars = 10 μm. (B) The percentage of TRNs showing the syncytium labeled by various TRN markers, including uIs31[mec-17p::GFP], unkEx309, and unkEx313. (C) Similar morphology of the SDQR neuron in wild-type and lem-3(−) mutants that possess the AVM-SDQR syncytium. (D) The two cell bodies in the AVM-SDQR and PLMR-ALNR syncytia both contain histones labeled by oxTi75[eft-3p::GFP::H2B]. Arrows point to the histone-containing nuclei. “Z1” and “Z2” indicate two focal planes of the same animal. (E) The AVM-SDQR syncytium expresses various SDQR markers, including ynIs25[flp-12p::gfp], ast-1::GFP(vlc19), and otIs358[ser-2p2::GFP]. (F) The PVM-SDQL syncytium is labeled by SDQL markers, flp-12p::GFP and ast-1::GFP. Because ser-2p2p::GFP is expressed in both PVM and SDQL in the wild-type animals, it cannot be used as an SDQL-specific marker for the syncytium. As expected, the PVM-SDQL syncytium shows ser-2p2p::GFP expression. The data underlying this Figure can be found in S1 Data.

    (TIF)

    S2 Fig. Repression of sister cell fate markers in ALM-BDU and PLM-ALN syncytia.

    (A, B) The lack of expression (dashed circles) of BDU fate markers unkEx914[nlp-80p::GFP], unkEx917[C15C7.4p::GFP], and otIs92[flp-10::GFP] in the ALM-BDU syncytium of lem-3(unk84) mutants. The persistent expression of BDU fate markers, wgIs73[ceh-14::EGFP] (circles) and otIs358[ser-2p2::GFP], in the syncytium. Scale bars = 10 μm. “Z1” and “Z2” indicate two focal planes of the same animal. (C) The comparison of morphology of the BDU neurons labeled by otIs358 in the wild-type animals and the BDU of the ALM-BDU syncytium labeled by uIs115[mec-17p::TagRFP] in lem-3(unk84) mutants. (D, E) The absence of expression (dashed circles) of ALN fate markers rtEx332[nlp-20p::GFP], ast-1::GFP(vlc19), and otIs358[ser-2p2::GFP] in the PLM-ALN syncytia. For the case of otIs358[ser-2p2::GFP], two scenarios were shown. One shows only the PLMR-ALNR syncytium and wild-type PLML; the other shows both the PLML-ALNL and the PLMR-ALNR syncytia.

    (TIF)

    pbio.3004099.s002.tif (9.9MB, tif)
    S3 Fig. Misexpression of mec-3 converts BDU and ALN into TRN-like cells.

    (A) BDU neurons express the TRN marker uIs115 and do not express the BDU fate markers otIs358[ser-2p2::GFP] and otIs14[zig-3p::GFP] in the animals carrying the uIs158[unc-119p::mec-3] transgene. SDQR expresses the TRN marker but also keeps the expression of the SDQ marker otIs358 upon mec-3 misexpression. Dashed circles indicate the lack of expression. Scale bars = 10 μm. Neuron names with an asterisk mean that the neuron abnormally expresses the TRN marker upon forced expression of mec-3. (B) ALN neurons express the TRN fate marker uIs115[mec-17p::TagRFP] and lose the expression of ALN markers otIs358[ser-2p2::GFP] and uIs130[lad-2p::GFP] in animals carrying the uIs158[unc-119p::mec-3] transgene. Wild-type expression pattern of otIs358[ser-2p2::GFP] in the tail can be found in S2B Fig for comparison. (C) SDQR expresses both the TRN marker uIs115 and the SDQ marker uIs130[lad-2p::GFP] in animals carrying the uIs158 transgene.

    (TIF)

    pbio.3004099.s003.tif (5.8MB, tif)
    S4 Fig. MEC-3 is required for the activation of TRN fate in the sister cells of the TRN-sister syncytia.

    (A) Various mec-3 null alleles generated in this study. (B) The loss of TRN fate marker mec-17p::TagRFP in mec-3(unk400) and lem-3(unk84); mec-3(unk398) animals. The ALN-PLM syncytium expressed the ALN marker lad-2p::GFP. (C) The TRN fate marker mec-17p::TagRFP was not expressed in mec-3(unk402) and lem-3(unk84); mec-3(unk403) animals. In both animals, ALM expressed the BDU marker zig-3p::GFP. (D, E) The TRN marker mec-17p::TagRFP was not expressed in mec-3(unk400) and lem-3(unk84); mec-3(unk398) animals. The AVM-SDQR and PVM-SDQL syncytia expressed the SDQ marker lad-2p::GFP. Scale bars, 10 μm.

    (TIF)

    pbio.3004099.s004.tif (4.9MB, tif)
    S5 Fig. Endogenous expression of TRN and sister cell fate markers in wild-type TRNs and sister cells, respectively.

    (A–D) smFISH against various cell fate markers was done in wild-type animals carrying the uIs31[mec-17p::GFP] transgene that marks the TRNs. (A) smFISH signals for the mRNAs of TRN genes mec-17, mec-18, and mec-3 in wild-type animals. Dashed orange circles indicate the cell bodies. The uIs31[mec-17p::GFP] transgene was used to label the TRNs. Scale bars = 5 μm. (B) Lack of smFISH signals for SDQ marker genes lad-2, ast-1, and flp-12 in AVM and PVM neurons. SDQR marker ser-2 mRNAs are not found in AVM but are found in 100% (n = 10) of PVM neurons. (C) smFISH signals for BDU fate markers nlp-80, D2089.3, and C15C7.4 are not observed in ALM neurons. ser-2 smFISH signals are found in 62.5% (n = 40) of ALM neurons. (D) smFISH signals for ALN fate markers nlp-20, ast-1, and lad-2 are not found in PLM neurons. ser-2 smFISH signals are found in 60% (n = 40) of PLM neurons. (E–H) smFISH against various cell fate markers was done in wild-type animals carrying the otIs358[ser-2p2::GFP] transgene that marks the sister cells of TRNs. (E) smFISH signals for the TRN fate markers mec-17, mec-18, and mec-3 are not found in the sister cells of TRNs in the wild-type animals. Dashed orange circles indicate the cell bodies. Scale bars = 5 μm. (F) smFISH signals for the SDQ marker genes lad-2, ast-1, and flp-12 in SDQL/R neurons. ser-2 only serves as a SDQR marker, although its mRNAs are found in both SDQL and SDQR. (G) smFISH signals for BDU fate markers nlp-80, D2089.3, C15C7.4, and ser-2 in BDUL/R neurons. (H) smFISH signals for ALN fate markers nlp-20, ast-1, lad-2, and ser-2 in ALNL/R neurons.

    (TIF)

    pbio.3004099.s005.tif (16.2MB, tif)
    S6 Fig. Additional evidence for the activation of endogenous fate markers in the two cell bodies of the syncytia.

    (A) smFISH signals for the mRNAs of TRN genes (mec-17, mec-18, and mec-3) and SDQL genes (lad-2, ast-1, and flp-12) in the two cell bodies of the PVM-SDQL syncytia in lem-3(unk84) mutants (n ≥ 10). Dashed circles indicate the cell bodies. “Z1” and “Z2” indicate different focal planes of the same animal. Arrows point to the intercellular bridge. Scale bars = 5 μm. (B) ser-2 smFISH signals are absent in the BDU cell body for 13% of the ALM-BDU syncytia (n = 15). (C) ser-2 smFISH signals are absent in the ALN cell body for 38% of the PLM-ALN syncytia (n = 21). (D) smFISH signals for GFP mRNAs in the lem-3(unk84); uIs31[mec-17p::GFP] strain with the percentage of cells having the shown smFISH staining patterns (n ≥ 10).

    (TIF)

    pbio.3004099.s006.tif (6.7MB, tif)
    S7 Fig. The intercellular bridge enables the exchange of cytoplasmic content between the TRNs and their sister cells in the syncytia.

    (A) Photoconversion of dendra2 in the ALM cell body of the ALM-BDU syncytium led to the increase of red fluorescence in BDU neuron (dashed circle). The times indicate the time points after photoconversion. Scale bars = 5 μm. (B) Quantification of the red fluorescence in both ALM and BDU cell bodies throughout the course of the photoconversion experiment. (C, D) After the connection between ALM and BDU cell bodies was cut using a laser, the photoconversion of dendra2 in ALM no longer caused the increase of red fluorescence in BDU neuron. (E, F) After cutting the intercellular bridge between AVM and SDQR, photoconversion of dendra2 in AVM did not lead to the increase of red fluorescence in SDQR. lem-3(unk84); unkEx271[mec-17p::dendra2] was used in these experiments. The data underlying this Figure can be found in S1 Data.

    (TIF)

    pbio.3004099.s007.tif (1.9MB, tif)
    S8 Fig. Intercellular bridge and nuclear envelope connection in the TRN-sister cell syncytia are maintained throughout development and aging.

    (A) Quantification of the distance between the two nuclei of the AVM-SDQR syncytia at different developmental stages. lem-3(unk84); uIs115[mec-17p::RFP]; ccIs4810[lmn-1p::lmn-1::GFP] was used to label both the cytosol and nuclear envelope. The syncytia with nuclear envelope (NE) links were marked in red in the plot. (B) Representative images of syncytia with a long NE link or with unseparated nuclei at 72 hours post L1 arrest recovery are shown. Scale bars = 10 μm. (C) Intercellular bridge (arrows) of ALM-BDU and AVM-SDQR syncytia at the day 5 adult stage in lem-3(unk84) mutants. The data underlying this Figure can be found in S1 Data.

    (TIF)

    pbio.3004099.s008.tif (2.9MB, tif)
    S9 Fig. Formation of syncytia between neurons and their apoptotic sisters and between pairs of sister cells in lem-3(−) mutants.

    (A) The sister cell of PVDL/R is apoptotic. In the lem-3(unk84); wyIs592[ser-2p3::myr::GFP] animals, which labels the PVD neuron, both syncytia of PVD with an extra cell (“syn”) and the loss of PVD labeling (“loss”) are found. For the former phenotype, arrows point to the bridge and for the latter phenotype, a dashed circle indicates the absence of GFP signal. Scale bars = 5 μm. “Z1” and “Z2” indicate different focal planes of the same animal. (B) The syncytia and the loss of fate marker phenotypes for NSM neurons in the lem-3(−) mutants. (C–G) Representative images of syncytia (“syn”) and fate marker loss (“loss” and dashed circles) phenotypes for URXL/R, ADFL/R, AIYL/R, FLPL/R, and HSNL/R neurons in lem-3(unk84) mutants. In syncytia, sister cells abnormally expressing markers are labeled with yellow names; arrows indicate the intercellular bridge. Quantification of penetrance is shown in Fig 7F. (H) The syncytium phenotype for the RIS neuron in lem-3(unk84) mutants treated with 10 μM ICRF-193.

    (TIF)

    pbio.3004099.s009.tif (5.5MB, tif)
    S1 Table. Strains, constructs, and primers used in this study.

    (XLSX)

    pbio.3004099.s010.xlsx (13.8KB, xlsx)
    S2 Table. smFISH probe sets used in this study.

    (XLSX)

    pbio.3004099.s011.xlsx (28.5KB, xlsx)
    S1 Data. Numeric data underlying all main and supporting figures.

    (XLSX)

    pbio.3004099.s012.xlsx (20.1KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewer Feedback for PBIOLOGY.docx

    pbio.3004099.s015.docx (24.6KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewer_Feedback_for_PBIOLOGY_auresp_3.docx

    pbio.3004099.s016.docx (24.6KB, docx)

    Data Availability Statement

    All data for this study are available within the paper and its Supporting information files. All individual numerical values underlying the figures are provided in the Supporting information file S1 Data.


    Articles from PLOS Biology are provided here courtesy of PLOS

    RESOURCES